( (TITLE (S (NP-SBJ (NP (DT An) (NN isoform)) (PP (IN of) (NP (NN ZBP) (HYPH -) (CD 89)))) (VP (VBZ predisposes) (NP (DT the) (NN colon)) (PP (IN to) (NP (NN colitis)))))) )
( (HEADING (NP (NN Abstract))) )
( (S (NP-SBJ (JJ Alternative) (NN splicing)) (VP (VBZ enables) (NP (NP (NN expression)) (PP (IN of) (NP (ADJP (RB functionally) (JJ diverse)) (NN protein) (NNS isoforms))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (ADJP (JJ structural) (CC and) (JJ functional)) (NN complexity)) (PP (IN of) (NP (NP (NML (NN zinc) (HYPH -) (NN finger)) (NN transcription) (NN factor)) (NP (NN ZBP) (HYPH -) (CD 89))))) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (PRP it)) (VP (MD may) (VP (VB be) (PP-PRD (IN among) (NP (NP (DT the) (NN class)) (PP (IN of) (NP (ADJP (RB alternatively) (VBN spliced)) (NNS genes)))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD identified) (NP (NP (NP (DT a) (JJ human) (NML (NN ZBP) (HYPH -) (CD 89)) (NN splice) (NN isoform)) (-LRB- -LRB-) (NP (NN ZBP) (HYPH -) (NN 89ΔN))) (-RRB- -RRB-) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ lacks) (NP (NP (ADJP (NN amino) (JJ terminal)) (NNS residues) (NML (NML (CD 1)) (PP (SYM –) (NP (CD 127))))) (PP (IN of) (NP (NP (DT the) (NML (JJ full) (HYPH -) (NN length)) (NN protein)) (-LRB- -LRB-) (NP (NN ZBP) (HYPH -) (NN 89FL)))))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN mRNA)) (VP (VBD was) (VP (VBN co-expressed) (NP-1 (-NONE- *)) (PP (IN with) (NP (PRP$ its) (NML (NN ZBP) (HYPH -) (NN 89FL)) (NN cognate))) (PP-LOC (IN in) (NP (JJ gastrointestinal) (NML (NML (NN cell) (NNS lines)) (CC and) (NML (NNS tissues))))))) (. .)) )
( (S (ADVP (RB Similarly)) (, ,) (NP-SBJ-1 (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN protein)) (VP (VBD was) (VP (VBN expressed) (NP-1 (-NONE- *)))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB define) (NP (PRP$ its) (NN function)) (ADVP-MNR (FW in) (FW vivo))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD generated) (NP (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (ADJP (VB knock) (HYPH -) (RP in)) (NNS mice)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG targeting) (NP (NP (NN exon) (CD 4)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ encodes) (NP (DT the) (NN amino) (NN terminus)))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Homozygous) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NNS mice)) (, ,) (VP (VBG expressing) (NP (RB only) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN protein)))) (, ,) (VP (VBD experienced) (NP (NP (NN growth) (NN delay)) (, ,) (NP (VBN reduced) (NN viability)) (CC and) (NP (NP (VBN increased) (NN susceptibility)) (PP (IN to) (NP (NML (NN dextran) (NN sodium) (NN sulfate)) (NN colitis)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP-SBJ (NN ZBP) (HYPH -) (NN 89ΔN)) (VP (VBZ antagonizes) (NP (NML (NN ZBP) (HYPH -) (NN 89FL)) (NN function))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NP (JJ over) (HYPH -) (NN expression)) (PP (IN of) (NP (DT the) (VBN truncated) (NN isoform)))) (VP (VBZ disrupts) (NP (JJ gastrointestinal) (NN homeostasis))))))) (. .)) )
( (HEADING (NP (NN INTRODUCTION))) )
( (S (NP-SBJ (NP (JJ Alternative) (JJ pre-mRNA) (NN splicing)) (CC and) (NP (JJ multiple) (NN promoter) (NN usage))) (VP (VBP are) (NP-PRD (NP (JJ common) (NNS mechanisms)) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG increasing) (NP (JJ genetic) (NN complexity)))))) (PP-LOC (IN in) (NP (NP (NNS humans) (PRN (-LRB- -LRB-) (NP (CD 1)) (-RRB- -RRB-))) (CC and) (NP (NNS mice) (PRN (-LRB- -LRB-) (NP (CD 2)) (-RRB- -RRB-)))))) (. .)) )
( (S (S (NP-SBJ (ADJP (NN Genome) (HYPH -) (JJ wide)) (NNS analyses)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN majority)) (PP (IN of) (NP (JJ human) (NNS genes)))) (VP (VBP express) (NP (JJ alternative) (NN splice) (NNS isoforms)) (PRN (-LRB- -LRB-) (NP (CD 3)) (-RRB- -RRB-))))))) (CC and) (S (NP-SBJ (DT some) (NNS variants)) (VP (VBP contribute) (PP (IN to) (NP (NP (NN neoplasia)) (CC or) (NP (JJ other) (NN disease) (NNS processes)))) (PRN (-LRB- -LRB-) (NP (CD 4) (, ,) (CD 5)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN For) (NP (NN example))) (, ,) (NP-SBJ (NP (VBN truncated) (NNS isoforms)) (PP (IN of) (NP (DT the) (NN p53) (NN gene) (NN family))) (, ,) (PP (VBG including) (NP (NP (NN p63) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-))) (CC and) (NP (NN p73) (PRN (-LRB- -LRB-) (NP (NP (CD 7)) (PP (SYM –) (NP (CD 9)))) (-RRB- -RRB-)))))) (, ,) (VP (VP (VBP oppose) (NP (NP (DT the) (NML (NN tumor) (NN suppressor)) (NN activity)) (PP (IN of) (NP (PRP$ their) (NML (JJ full) (HYPH -) (NN length)) (NNS cognates))))) (CC and) (VP (VBP are) (ADJP-PRD (RB over) (HYPH -) (VBN expressed)) (PP-LOC (IN in) (NP (NNS tumors))))) (. .)) )
( (S (NP-SBJ (NP (NN ZBP) (HYPH -) (CD 89) (PRN (-LRB- -LRB-) (NP (NN ZNF148) (: ;) (NN Zfp148) (: ;) (NN BFCOL1)) (-RRB- -RRB-))) (, ,) (NP (DT a) (NML (NN Krüppel) (HYPH -) (NN type)) (NML (NN zinc) (HYPH -) (NN finger)) (NN protein) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-)))) (, ,) (VP (VBZ is) (ADJP-PRD (CC both) (ADVP (ADVP (RB structurally) (PRN (-LRB- -LRB-) (NP (CD 11)) (-RRB- -RRB-))) (CC and) (ADVP (RB functionally))) (JJ complex) (PRN (-LRB- -LRB-) (NP (NP (CD 12)) (PP (SYM –) (NP (CD 14)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (PRP It)) (VP (VBZ regulates) (NP (JJ diverse) (JJ biological) (NNS functions)) (PP-MNR (PP (IN through) (NP (JJ direct) (NN promoter) (NN binding) (PRN (-LRB- -LRB-) (NP (CD 10)) (, ,) (NP (CD 14)) (-RRB- -RRB-)))) (CC and) (PP (IN through) (NP (JJ multiple) (NML (NN protein) (SYM –) (NN protein)) (NNS interactions))))) (. .)) )
( (S (NP-SBJ (PRP It)) (VP (VP (VBZ interacts) (ADVP=2 (RB directly)) (PP=1 (IN with) (NP (NP (DT the) (NN tumor) (NN suppressor)) (NP (NN p53)))) (PP-MNR=3 (IN through) (NP (PRP$ its) (NML (NN zinc) (HYPH -) (NN finger)) (NN domain) (PRN (-LRB- -LRB-) (NP (CD 13)) (-RRB- -RRB-))))) (CC and) (VP (ADVP=2 (RB indirectly)) (PP=1 (IN with) (NP (NP (DT the) (NML (NML (NN histone) (NN acetyltransferase)) (CC and) (NML (JJ transcriptional) (NN co-activator)))) (NP (NN p300)))) (PP-MNR=3 (IN through) (NP (PRP$ its) (NN amino) (NN terminus) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (NN ZBP) (HYPH -) (CD 89)) (VP (VP (VBZ induces) (NP=2 (NML (NN cell) (NN growth)) (NN arrest)) (PP-MNR=1 (IN through) (NP (DT a) (ADJP (NN p53) (HYPH -) (JJ dependent)) (NN mechanism))) (PRN (-LRB- -LRB-) (NP (CD 13)) (-RRB- -RRB-))) (CC and) (VP (NP=2 (NN apoptosis)) (PP-MNR=1 (IN through) (NP (DT a) (ADJP (NN p53) (HYPH -) (JJ independent)) (NN mechanism))) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (NNS Mice)) (ADJP (JJ haploinsufficient) (PP (IN for) (NP (NP (NN ZBP) (HYPH -) (CD 89)) (-LRB- -LRB-) (NP (NN Zfp148)))))) (-RRB- -RRB-) (VP (VBP are) (ADJP-PRD (JJ sterile)) (PP-PRP (VBG owing) (PP (IN to) (NP (JJ aberrant) (NN spermatogenesis)))) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-1 (NP (JJ embryonic) (NN stem) (NNS cells)) (VP (VBG harboring) (NP (DT a) (JJ single) (NML (NN ZBP) (HYPH -) (CD 89)) (NN allele)))) (VP (VBP fail) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB exhibit) (NP (NN p53) (NN phosphorylation)) (PP-LOC (IN at) (NP (NN Ser) (CD 15))) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (NN ZBP) (HYPH -) (CD 89)) (VP (VBZ forms) (NP (NP (DT a) (NN complex)) (PP (IN with) (NP (NN p300)))) (PP-TMP (IN during) (NP (NP (NN butyrate) (NN induction)) (PP (IN of) (NP (NN p21waf1))))) (PP-LOC (IN in) (NP (JJ human) (JJ colorectal) (NN cell) (NNS lines))) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN amino) (NN terminus)) (PP (IN of) (NP (NN ZBP) (HYPH -) (CD 89)))) (VP (VBZ contains) (NP (NP (DT an) (JJ acidic) (NN domain)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (VP (VBN required) (NP-1 (-NONE- *)) (PP (IN for) (NP (ADJP (NN p300) (HYPH -) (VBN mediated)) (NN induction)))))))) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ (NP (DT an) (NN expression) (NN construct)) (VP (VBG lacking) (NP (DT this) (NN domain) (PRN (-LRB- -LRB-) (NP (NN Δ) (NN amino) (NNS acids) (NML (NML (CD 1)) (PP (SYM –) (NP (CD 113))))) (-RRB- -RRB-))))) (VP (VBZ loses) (NP (PRP$ its) (NN ability) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB enhance) (NP (NP (NN butyrate) (NN induction)) (PP (IN of) (NP (NN p21waf1)))))))) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ acidic) (NN domain)) (PP (IN of) (NP (NN ZBP) (HYPH -) (CD 89)))) (VP (VBZ is) (VP (VBN contained) (NP-1 (-NONE- *)) (ADVP (RB entirely)) (PP-LOC (IN within) (NP (NP (NN exon) (CD 4)) (PP (IN of) (NP (DT the) (UCP (JJ human) (CC and) (NN mouse)) (NNS genes))))) (PRN (-LRB- -LRB-) (NP (CD 11)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (VBN Given) (NP (NP (DT the) (JJ heterogeneous) (NML (NN ZBP) (HYPH -) (CD 89)) (NN mRNA) (NN expression) (NN pattern) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-))) (, ,) (NP (NP (DT the) (JJ functional) (NN importance)) (PP (IN of) (NP (DT the) (NML (NN p300) (NN interaction)) (NN domain)))) (, ,) (CC and) (NP (DT the) (NN fact) (SBAR (IN that) (S (NP-SBJ (DT the) (ADJP (NP (NN ZBP) (HYPH -) (CD 89)) (JJ null)) (NN mouse)) (VP (VBZ is) (ADVP (RB likely)) (NP-PRD (DT an) (JJ embryonic) (JJ lethal)) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-)))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD generated) (NP (NP (DT a) (NN mouse)) (ADJP (JJ homozygous) (PP (IN for) (NP (DT the) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN isoform)))))) (. .)) )
( (S (NP-SBJ (JJ Homozygous) (NN ΔNter) (NNS mice)) (VP (VBD experienced) (NP (NP (NN growth) (NN delay)) (, ,) (NP (VBN reduced) (NN viability)) (CC and) (NP (NP (VBN increased) (NN susceptibility)) (PP (IN to) (NP (ADJP (NP (NP (NN Dextran) (NN sodium) (NN sulfate)) (-LRB- -LRB-) (NP (NN DSS))) (-RRB- -RRB-) (VBN induced)) (NN colitis))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NP (RB over) (HYPH -) (NN expression)) (PP (IN of) (NP (DT the) (NN ΔNter) (NN isoform)))) (VP (VBZ disrupts) (NP (JJ normal) (JJ gastrointestinal) (NN homeostasis)))))))) (. .)) )
( (HEADING (NP (NNS MATERIALS) (CC AND) (NNS METHODS))) )
( (HEADING (NP (NN Database) (NN deposition))) )
( (S (NP-SBJ (NP (NML (NML (NP (NNP National) (NNP Center)) (PP (IN for) (NP (NNP Biotechnology) (NNP Information)))) (-LRB- -LRB-) (NML (NNP NCBI))) (-RRB- -RRB-) (NN reference) (NNS sequences)) (PP (IN for) (NP (NML (NN ZBP) (HYPH -) (CD 89)) (JJ genomic) (NNS loci)))) (VP (VBP are) (NP-PRD (NP (NML (NNP Homo) (NNP sapiens)) (NML (NN chromosome) (CD 3)) (NN locus) (NN NC_000003)) (CC and) (NP (NN BAC) (NN RP11) (HYPH -) (NN 775J23) (PRN (-LRB- -LRB-) (NP (NN AC108688)) (-RRB- -RRB-))) (: ;) (NP (NML (NN Mus) (NN musculus)) (NML (NN chromosome) (CD 16)) (NN contig) (NN NT_039624)) (CC and) (NP (NML (NN Pan) (NNS troglodytes)) (NML (NN chromosome) (CD 3)) (JJ genomic) (NN locus) (NN NW_104931)))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NML (NML (JJ human) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN mRNA)) (CC and) (NML (NML (NN exon) (NN 4B)) (JJ genomic) (NNS sequences)))) (VP (VBN reported) (NP (-NONE- *)) (ADVP (RB here)))) (VP (VBP are) (VP (VBN found) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NNP GenBank))) (PP (IN as) (NP (NNS entries) (NML (NN DQ090088) (CC and) (NN DQ090089)))) (, ,) (ADVP (RB respectively)))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN P.troglodytes) (JJ genomic) (NN sequence)) (ADJP (JJ homologous) (PP (IN to) (NP (JJ human) (NN exon) (NN 4B))))) (VP (VBZ is) (VP (VBN deposited) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NNP Genbank) (NN DQ144540))))) (. .)) )
( (HEADING (NP (NP (NN Organization)) (PP (IN of) (NP (DT the) (NML (NML (JJ human) (PRN (-LRB- -LRB-) (NP (NN ZNF148)) (-RRB- -RRB-))) (, ,) (NML (NN chimp)) (CC and) (NML (NN mouse) (PRN (-LRB- -LRB-) (NP (NN Zfp148)) (-RRB- -RRB-)))) (NML (NML (NN ZBP) (HYPH -) (CD 89)) (NNS loci)))))) )
( (S (NP-SBJ-1 (NP (DT A) (JJ human) (JJ genomic) (NN clone) (NN contig)) (VP (VBG encompassing) (NP (DT the) (NML (NN ZBP) (HYPH -) (CD 89)) (NN locus)))) (VP (VBD was) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (CD 14)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NML (NML (JJ Bacterial) (JJ artificial) (NN chromosome)) (-LRB- -LRB-) (NML (NN BAC))) (-RRB- -RRB-) (NNS clones)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN as) (NP (NNS templates))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB sequence) (NP (NP (NML (NN intron) (HYPH /) (NN exon)) (NNS boundaries)) (VP (VBG spanning) (NP (DT the) (NN ZNF148) (NN locus))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Exon) (NN 4B)) (VP (VBD was) (VP (VBN identified) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NML (NN gene) (NN prediction)) (NN sequence) (NN analysis))) (PRN (-LRB- -LRB-) (NP (CD 16) (, ,) (CD 17)) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB Similarly)) (, ,) (NP-SBJ-1 (NP (DT a) (NML (NML (NN BAC)) (CC and) (NML (NN bacteriophage) (NN lambda))) (NN clone) (NN contig)) (VP (VBG spanning) (NP (DT the) (NN mouse) (NN Zfp148) (NN locus)))) (VP (VBD was) (VP (VBN assembled) (CC and) (VBN sequenced) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (NP (DT the) (JJ genomic) (NN organization)) (PP (IN of) (NP (DT the) (NN Zfp148) (NN locus))))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Primers) (NML (NML (NML (NN Ptr) (HYPH -) (NN 4B) (HYPH -) (NN F)) (: :) (NML (NML (CD 5) (SYM ′)) (HYPH -) (NN TTCACCTCCCTGTCCTGTTC) (HYPH -) (CD 3) (SYM ′))) (CC and) (NML (NML (NN Ptr) (HYPH -) (NN 4B) (HYPH -) (NN R)) (: :) (NML (NML (CD 5) (SYM ′)) (HYPH -) (NN TATCTGTCCCGTTTGCCTG) (HYPH -) (CD 3) (SYM ′))))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB amplify) (CC and) (VB sequence) (NP (NP (NML (NN chimp) (PRN (-LRB- -LRB-) (NP (NN P.troglodytes)) (-RRB- -RRB-))) (JJ genomic) (NN DNA)) (VP (VBG containing) (NP (NN exon) (NN 4B))))))) (, ,) (SBAR-TMP (IN after) (S (NP-SBJ (NNP BLAST) (NN analysis) (PRN (-LRB- -LRB-) (NP (CD 18)) (-RRB- -RRB-))) (VP (VBD had) (VP (VBN revealed) (NP (DT a) (NN sequence) (NN gap)) (PP-LOC (IN in) (NP (DT this) (NN region))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Chimp) (JJ genomic) (NN DNA)) (VP (VBD was) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP (IN from) (NP (DT the) (NNP Integrated) (NNP Primate) (NML (NNP Biomaterials) (CC and) (NNP Information)) (NNP Resource))) (PP-MNR (IN through) (NP (NP (DT the) (NNP Coriell) (NNP Institute)) (PP (IN for) (NP (NNP Medical) (NNP Research))) (PRN (-LRB- -LRB-) (NP (NP (NNP Camden)) (, ,) (NP-LOC (NNP NJ))) (-RRB- -RRB-)))))) (. .)) )
( (HEADING (NP (NML (NN RT) (HYPH –) (NN PCR)) (NN analysis))) )
( (S (NP-SBJ-1 (JJ Total) (JJ cellular) (NN RNA)) (VP (VBD was) (VP (VBN isolated) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (VBN cultured) (NNS cells)) (VP (VBG using) (NP (NN TRIzol) (NN reagent) (PRN (-LRB- -LRB-) (NP (NP (NNP Invitrogen)) (, ,) (NP-LOC (NNP Carlsbad)) (, ,) (NP-LOC (NNP CA))) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (VBN Archived) (NML (JJ whole) (NN cell)) (NN RNA) (NNS samples)) (PP (IN from) (NP (VBN paired) (UCP (NML (NN colon) (NN cancer)) (CC and) (ADJP (JJ normal) (JJ mucosal))) (NNS samples)))) (VP (VBD were) (ADVP (RB also)) (VP (VBN analyzed) (NP-1 (-NONE- *)))) (. .)) )
( (S (S (NP-SBJ-2 (NML (CD Two) (HYPH -) (NN step)) (NN RT) (HYPH –) (NN PCR)) (VP (VBD was) (VP (VBN performed) (NP-2 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NN SuperScript) (CD III) (NN RT) (PRN (-LRB- -LRB-) (NP (NNP Invitrogen)) (-RRB- -RRB-)))))))) (, ,) (S (ADVP (RB however)) (NP-SBJ-1 (JJ reverse) (NN transcription)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN at) (NP (CD 55) (NN °C))) (PP-PRP (IN in) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB obtain) (NP (NP (JJ adequate) (NNS yields)) (PP (IN of) (NP (JJ human) (ADJP (NP (NN exon) (NN 4B)) (HYPH -) (VBG containing)) (NN cDNA)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NN RT) (NNS reactions)) (VP (VBD were) (VP (VBN primed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (JJ random) (NNS nonamers))))) (. .)) )
( (S (NP-SBJ (JJ Human) (NN primer) (NNS sequences) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (SYM ′)) (PP (IN to) (NP (CD 3) (SYM ′)))) (-RRB- -RRB-))) (VP (VBD were) (NP-PRD (NP (NML (NN 4A) (HYPH -) (NN F)) (: :) (NN ATGAACATTGACGACAAACTGGAAG)) (: ;) (NP (NML (CD 5) (HYPH -) (NN R)) (: :) (NN TTCCATATGATATTTTTGTATGAAT)) (: ;) (NP (NML (NN 4B) (HYPH -) (NN F)) (: :) (NN TAGGGATGGTCAGCACTG)) (: ;) (NP (NML (CD 6) (HYPH -) (NN R)) (: :) (NN GTTCTTTTGTGCCTTTCC)))) (. .)) )
( (S (NP-SBJ (NN Mouse) (NN primer) (NNS sequences) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (NN ′)) (PP (IN to) (NP (CD 3) (NN ′)))) (-RRB- -RRB-))) (VP (VBD included) (NP (NP (NML (NN Ex2) (HYPH -) (NN F)) (: :) (NN GCGGATAGAAGAGAAGAATCAGTGG)) (: ;) (NP (NML (NN Ex4) (HYPH -) (NN F)) (: :) (NN CATTGACGACAAACTGGAAGG)) (: ;) (NP (NML (NN Ex4) (HYPH -) (NN R)) (: :) (NN ACTTCGATCTTGAAGTACTGACTC)) (: ;) (NP (NML (NN Ex5) (HYPH -) (NN R)) (: :) (NN CAGGAGAGCGTTGTTTCCG)) (: ;) (NP (NML (NN Ex3) (HYPH /) (NN 5fusion) (HYPH -) (NN F)) (: :) (NN CAGCCTCAGATAAGTGTA)) (CC and) (NP (NML (NN Ex9) (HYPH -) (NN R)) (: :) (NN TTGTGGCATCTGGTGAAG)))) (. .)) )
( (S (NP-SBJ-1 (NML (NN RT) (HYPH –) (NN PCR)) (NNS products)) (VP (VBD were) (VP (VBN purified) (CC and) (VBN subjected) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN DNA) (NN sequence) (NN analysis))) (PRN (-LRB- -LRB-) (NP (NML (NML (NNP University)) (PP (IN of) (NP (NNP Michigan)))) (NML (NNP DNA) (NNP Sequencing)) (NNP Core)) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NP (NML (CD 5) (SYM ′)) (HYPH -) (NN RACE)) (PP (IN of) (NP (JJ human) (NN exon) (NN 4B))))) )
( (S (NP-SBJ-1 (NP (DT The) (NML (CD 5) (SYM ′)) (NN end)) (PP (IN of) (NP (DT the) (NML (NN exon) (NN 4B)) (NN variant)))) (VP (VBD was) (VP (VBN identified) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT the) (NML (NNP GeneRacer) (SYM ™)) (NN system) (PRN (-LRB- -LRB-) (NP (NP (NNP Invitrogen)) (, ,) (NP-LOC (NNP Carlsbad)) (, ,) (NP-LOC (NNP CA))) (-RRB- -RRB-))) (, ,) (NP (NP (ADJP (NN gene) (JJ specific)) (NN primer) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (SYM ′)) (PP (IN to) (NP (CD 3) (SYM ′)))) (-RRB- -RRB-))) (NP (NML (NN 4B211) (HYPH -) (NN Rev)) (: :) (NN CAGTGCTGACCATCCCTATC) (NN CTACTTG))) (CC and) (NP (NP (CD 2) (NN µg)) (PP (IN of) (NP (NN Jurkat) (NML (JJ whole) (NN cell)) (NN RNA))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (VBN Nested) (NN PCR) (NNS products)) (, ,) (VP (VBN generated) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN adaptor) (NNS primers)) (VP (VBN included) (NP (-NONE- *)) (PP (IN with) (NP (DT the) (NML (NNP GeneRacer) (SYM ™)) (NN system)))))))) (, ,) (VP (VBD were) (VP (VP (VBN cloned) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NML (NN TOPO) (HYPH -) (NN TA)) (NN system)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Invitrogen)) (, ,) (NP-LOC (NNP Carlsbad)) (, ,) (NP-LOC (NNP CA))) (-RRB- -RRB-))) (, ,) (CC and) (VP (VBN sequenced) (NP-1 (-NONE- *))))) (. .)) )
( (HEADING (NP (NN Targeting) (NN vector))) )
( (S (NP-SBJ (PRP We)) (VP (VBD constructed) (NP (NN vector) (NN pΔEx) (HYPH -) (CD 4)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB replace) (NP (NML (NN ZBP) (HYPH -) (CD 89)) (NN exon) (CD 4)) (PP (IN with) (NP (DT a) (NML (NN PGK) (HYPH -) (NN Neo)) (NN cassette))) (PP-MNR (IN by) (NP (JJ homologous) (NN recombination))))))) (. .)) )
( (S (NP-SBJ-1 (NML (JJ High) (NN fidelity)) (NML (JJ long) (HYPH -) (NN range)) (NN PCR)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB amplify) (NP (VBG targeting) (NNS arms)) (PP (IN from) (NP (NP (NN mouse) (NN BAC) (NN clone)) (NP (NN pBmZBP) (HYPH -) (CD 89))))))) (, ,) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VP (VBG using) (NP=2 (NP (NNS primers) (NML (-LRB- -LRB-) (NP (NP (CD 5) (SYM ′)) (PP (IN to) (NP (CD 3) (SYM ′)))) (-RRB- -RRB-))) (: :) (NP (-LRB- -LRB-) (NN Kpn) (-RRB- -RRB-) (NML (NN Int3) (HYPH -) (NN F)) (, ,) (NN GATAGGTACCGCATTGGATGGCACAAGTGACTGAGAGG))) (PP (IN with) (NP (-LRB- -LRB-) (NN Xho) (-RRB- -RRB-) (NML (NN Int3) (HYPH -) (NN R)) (, ,) (NN CTCGAGCCCGGGCTTAAGTATAACTGCCTAGAAAG))) (PP=4 (IN for) (NP (DT the) (JJ left) (NN arm)))) (CC and) (VP (NP=2 (-LRB- -LRB-) (NN Apa) (-RRB- -RRB-) (NML (NN Int4) (HYPH -) (NN F)) (, ,) (NN CTCGAGGGGCCCGTAAGTACTAAACTAGAAATG)) (PP=3 (IN with) (NP (-LRB- -LRB-) (NN Apa) (-RRB- -RRB-) (NML (NN Int4) (HYPH -) (NN R)) (, ,) (NN CTCGAGGGGCCCAAGAGCCTTGCTGACTCATAG))) (PP=4 (IN for) (NP (DT the) (JJ right) (NN arm)))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ left) (NN targeting) (NN arm)) (, ,) (VP (VBG encompassing) (NP (NP (NN exon) (CD 3)) (CC and) (NP (NN intron) (CD 3))))) (, ,) (VP (VBD was) (NP-PRD (NP (CD 8) (NN kb)) (PP (IN in) (NP (NN length))))) (. .)) )
( (S (NP-SBJ (DT The) (NML (JJ right) (NN targeting)) (NN arm)) (VP (VBD consisted) (PP (IN of) (NP (NP (DT the) (JJ proximal) (CD 2) (NN kb)) (PP (IN of) (NP (NN intron) (CD 4)))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN neomycin) (NN cassette)) (, ,) (PP (VBG including) (NP (DT a) (JJ transcriptional) (NN stop) (NN signal)))) (, ,) (VP (VBD was) (VP (VBN isolated) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NN pPNT) (PRN (-LRB- -LRB-) (NP (CD 19)) (-RRB- -RRB-))) (, ,) (VP (ADVP (RB generously)) (VBN provided) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NNP Dr) (NNP Richard) (NNP Mulligan)))))))) (. .)) )
( (HEADING (NP (NP (NN Generation)) (PP (IN of) (NP (NP (VBN targeted) (NN ES) (NNS cells)) (CC and) (NP (NN ΔNter) (NNS mice)))))) )
( (S (NP-SBJ-1 (NP (NP (NN Electroporation)) (PP (IN of) (NP (NML (NML (JJ embryonic) (NN stem)) (-LRB- -LRB-) (NML (NN ES))) (-RRB- -RRB-) (NNS cells))) (PP (IN with) (NP (DT the) (NML (NN pΔEx) (HYPH -) (CD 4)) (NN targeting) (NN vector)))) (CC and) (NP (NP (NN microinjection)) (PP (IN of) (NP (NNS blastocysts))) (PP (IN with) (NP (VBN targeted) (NN ES) (NNS cells))))) (VP (VBD were) (VP (VBN performed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NML (NML (NNP University)) (PP (IN of) (NP (NNP Michigan)))) (NML (NNP Transgenic) (NNP Animal) (NNP Model)) (NNP Core) (PRN (-LRB- -LRB-) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (JJ Genomic) (NN PCR)) (VP (VBD was) (VP (VBN utilized) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB genotype) (NP (NP (VBN targeted) (CD 129) (NML (NN Sv) (HYPH /) (NN J)) (NN ES) (NNS clones)) (, ,) (NP (JJ chimeric) (NNS founders)) (, ,) (CC and) (NP (NP (NN progeny)) (VP (VBG resulting) (PP-TMP (IN after) (NP (NN germline) (NN transmission))))))))))) (. .)) )
( (S (NP-SBJ (NN Primer) (NNS sequences) (PRN (-LRB- -LRB-) (NP (NP (CD 5) (SYM ′)) (PP (IN to) (NP (CD 3) (SYM ′)))) (-RRB- -RRB-))) (VP (VBD were) (NP-PRD (NP (NML (NN Int3) (HYPH -) (NN F1)) (, ,) (NN GGAGTATTCTCTGTCCGTT) (NN ATG)) (: ;) (NP (NML (NN Int4) (HYPH -) (NN 326R)) (, ,) (NN GCAAGAACTACACAGAGAAACCAC)) (CC and) (NP (NN R506Neo) (, ,) (NN TGAGGAA) (NN GAGGAGAACAGCG)))) (. .)) )
( (HEADING (NP (ADJP (CD Two) (HYPH -) (JJ dimensional)) (NML (NNP western) (NN blot)) (NN analysis))) )
( (S (NP-SBJ-1 (NML (JJ Whole) (NN cell)) (NN protein) (NNS extracts)) (VP (VBD were) (VP (VBN prepared) (NP-1 (-NONE- *)) (PP (IN from) (NP (NN mouse) (NN spleen))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NML (NN T) (HYPH -) (NN PER)) (NN tissue) (NN protein) (NN extraction) (NN reagent) (PRN (-LRB- -LRB-) (NP (NP (NNP Pierce)) (, ,) (NP-LOC (NNP Rockford)) (, ,) (NP-LOC (NNP IL))) (-RRB- -RRB-))) (, ,) (VP (VBN supplemented) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NNP Complete) (NNP Mini) (NN protease) (NNS inhibitors) (PRN (-LRB- -LRB-) (NP (NP (NNP Roche)) (, ,) (NP-LOC (NNP Indianapolis)) (, ,) (NP-LOC (NNP IN))) (-RRB- -RRB-)))) (PP-MNR (VBG according) (NP (NP (DT the) (NNS manufacturers) (POS ')) (NNS recommendations))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NML (JJ Whole) (NN cell)) (NN protein) (NNS extracts)) (PP (IN from) (NP (JJ human) (NN Jurkat) (NNS cells)))) (VP (VBD were) (ADVP (RB similarly)) (VP (VBN prepared) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (NN M) (HYPH -) (NN PER)) (JJ mammalian) (NN protein) (NN extraction) (NN reagent) (PRN (-LRB- -LRB-) (NP (NP (NNP Pierce)) (, ,) (NP-LOC (NNP Rockford)) (, ,) (NP-LOC (NNP IL))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Isoelectric) (NN focusing)) (-LRB- -LRB-) (NP (NN IEF))) (-RRB- -RRB-) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NML (CD 7) (NN cm)) (NML (NNP ZOOM) (SYM ®)) (NN Strip) (NML (NN ph3) (HYPH -) (NN 10L) (PRN (-LRB- -LRB-) (NP (JJ linear)) (-RRB- -RRB-))) (VBN immobilized) (NML (NN pH) (NN gradient)) (NNS gels) (PRN (-LRB- -LRB-) (NP (NP (NNP Invitrogen)) (, ,) (NP-LOC (NNP Carlsbad)) (, ,) (NP-LOC (NNP CA))) (-RRB- -RRB-)))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBN recommended) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN manufacturer)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (VBN focused) (NN proteins)) (VP (VBD were) (ADVP-TMP (RB then)) (VP (VBN separated) (NP-1 (-NONE- *)) (PP (IN on) (NP (NML (NNP NuPAGE) (SYM ®)) (NML (QP (CD 4) (SYM -) (CD 12)) (NN %)) (NN acrylamide) (NNS gels) (PRN (-LRB- -LRB-) (NP (NNP Invitrogen)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (NP (NP (NN Electroblot) (NN transfer)) (PP (IN to) (NP (NN PVDF) (NN membrane)))) (CC and) (NP (NP (NN immunoblot) (NNS procedures)) (PP (IN with) (NP (NML (NN ZBP) (HYPH -) (CD 89)) (NN antiserum))))) (VP (VBP are) (SBAR-PRD (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (CD 10) (, ,) (CD 12)) (-RRB- -RRB-)))))) (. .)) )
( (HEADING (NP (NML (NN Dextran) (NN sodium) (NN sulfate)) (NN colitis))) )
( (S (NP-SBJ-1 (NN DSS) (NN colitis)) (VP (VBD was) (VP (VBN induced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (NP (QP (CD 6) (SYM –) (CD 9)) (NN month)) (JJ old)) (NML (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (CC and) (NML (NN littermate) (NN control))) (NNS mice))) (PP-MNR (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NML (CD 4) (NN %)) (NN DSS))) (PP (IN to) (NP (NN drinking) (NN water))) (PP-TMP (IN for) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (CD 5) (NNS days))))))) (PRN (-LRB- -LRB-) (NP (CD 20)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (VBN Treated) (NNS mice)) (VP (VBD were) (VP (VBN returned) (NP-1 (-NONE- *)) (PP (IN to) (NP (JJ normal) (NN drinking) (NN water))) (PP-TMP (IN for) (NP (CD 2) (NNS days))) (PP-TMP (JJ prior) (PP (IN to) (NP (NP (NN necropsy)) (PP (IN for) (NP (JJ histopathological) (NN scoring)))))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (NP (NP (NN Hematoxylin) (CC and) (NN eosin)) (-LRB- -LRB-) (NP (NN H) (CC &) (NN E))) (-RRB- -RRB-) (VBN stained)) (NN colon) (NNS sections)) (VP (VP (VBD were) (VP (VBN prepared) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (DT the) (NML (NNP Swiss) (NNP roll)) (NN method) (PRN (-LRB- -LRB-) (NP (CD 21)) (-RRB- -RRB-)))))) (CC and) (VP (VBD were) (VP (VBN scored) (NP-1 (-NONE- *)) (PP (IN for) (NP (NN colitis) (NN index))) (PP-MNR (IN by) (NP (NP (DT a) (NN modification)) (PP (IN of) (NP (DT a) (ADJP (RB previously) (VBN described)) (NN method) (PRN (-LRB- -LRB-) (NP (CD 22)) (-RRB- -RRB-))))))))) (. .)) )
( (S (ADVP (RB Briefly)) (, ,) (NP-SBJ-1 (NN crypt) (NN damage)) (VP (VBD was) (VP (VBN scored) (NP-1 (-NONE- *)) (PP (PP (IN from) (NP (CD 0))) (PP (IN to) (NP (CD 3)))) (PP (IN as) (NP (NP (NN none)) (, ,) (NP (JJ basal) (RB only)) (, ,) (NP (JJ moderate) (NN damage)) (CC and) (NP (JJ complete) (NN erosion)))) (, ,) (ADVP (RB respectively)))) (. .)) )
( (S (NP-SBJ-1 (NN Inflammation)) (VP (VBD was) (VP (VBN scored) (NP-1 (-NONE- *)) (PP (PP (IN from) (NP (CD 0))) (PP (IN to) (NP (CD 3)))) (PP (IN as) (NP (UCP (NN none) (, ,) (JJ minor) (, ,) (JJ moderate) (CC and) (JJ severe)) (NN leukocyte) (NN infiltration))))) (. .)) )
( (S (NP-SBJ-1 (JJ Submucosal) (NN edema)) (VP (VBD was) (VP (VBN scored) (NP-1 (-NONE- *)) (PP (PP (IN from) (NP (CD 0))) (PP (IN to) (NP (CD 3)))) (PP (IN as) (UCP (NN none) (, ,) (JJ minor) (, ,) (JJ moderate) (CC and) (JJ severe))) (, ,) (ADVP (RB respectively)))) (. .)) )
( (S (ADVP (RB Similarly)) (, ,) (NP-SBJ-1 (NN hemorrhage)) (VP (VBD was) (VP (VBN scored) (NP-1 (-NONE- *)) (PP (PP (IN from) (NP (CD 0))) (PP (IN to) (NP (CD 3)))) (PP (IN as) (UCP (NN none) (, ,) (JJ minor) (, ,) (JJ moderate) (CC and) (JJ severe))))) (. .)) )
( (S (NP-SBJ-1 (DT Each) (NN parameter)) (VP (VBD was) (VP (VBN multiplied) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT an) (NN extent) (NN factor) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM –) (NP (CD 3)))) (-RRB- -RRB-))) (, ,) (NP (NP (QP (SYM <) (CD 10)) (NN %)) (, ,) (NP (QP (IN up) (IN to) (CD 25)) (NN %)) (, ,) (NP (QP (CD 25) (IN to) (CD 50)) (NN %)) (CC and) (NP (QP (SYM >) (CD 50)) (NN %))))) (, ,) (ADVP (RB respectively)))) (. .)) )
( (S (NP-SBJ (NP (NNS Samples)) (PP (IN with) (NP (JJ transmural) (NN involvement)))) (VP (VBD received) (NP (DT an) (JJ additional) (CD four) (NNS points))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (DT the) (NN maximum) (JJ possible) (NML (NN colitis) (NN index)) (NN score)) (VP (VBD was) (NP-PRD (CD 40))) (. .)) )
( (S (NP-SBJ-2 (NP (NNS Animals)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD died) (PP-TMP (IN during) (NP (NN treatment))) (PP-PRP (IN because) (IN of) (NP (NN colitis) (NN injury))))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN given) (NP-2 (-NONE- *)) (NP (DT the) (JJ maximum) (NN score)))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Individuals)) (VP (VBG scoring) (NP (DT the) (NNS samples)))) (VP (VBD were) (VP (VBN blinded) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT the) (NN genotype))))) (. .)) )
( (HEADING (NP (NN Cell) (NN culture))) )
( (S (NP-SBJ-1 (DT The) (VBG following) (NN cell) (NNS lines)) (VP (VBD were) (VP (VP (VBN obtained) (NP-1 (-NONE- *)) (PP (IN from) (NP (NN ATCC))) (PRN (-LRB- -LRB-) (NP (NP (NNP Manassas)) (, ,) (NP-LOC (NNP VA))) (-RRB- -RRB-))) (CC and) (VP (VBN maintained) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (NP (DT the) (VBN recommended) (NN growth) (NNS media)) (: :) (NP (NP (JJ Human) (JJ gastric) (JJ epithelial) (NNS cells) (NML (NML (NN Kato) (CD III)) (CC and) (NML (NN MKN45)))) (: ;) (NP (JJ human) (NN colon) (NN cancer) (NNS cells) (NML (NML (NN Colo) (NN 320DM)) (, ,) (NML (NN CaCo) (HYPH -) (CD 2)) (CC and) (NML (NN HCT116)))) (: ;) (CC and) (NP (JJ human) (NN Jurkat) (NN leukemia) (NNS cells)))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Cells)) (VP (VBD were) (VP (VBN cultured) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT a) (VBN humidified) (NN atmosphere)) (PP (IN of) (NP (NP (NML (CD 5) (NN %)) (NN CO2)) (CC and) (NP (NML (CD 95) (NN %)) (NN air)))) (PP (IN at) (NP (CD 37) (NN °C))))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NN culture) (NNS media)) (VP (VBD were) (VP (VBN supplemented) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN penicillin) (NN G) (PRN (-LRB- -LRB-) (NP (NP (CD 100) (NN U)) (PP (SYM /) (NP (NN ml)))) (-RRB- -RRB-))) (CC and) (NP (NN streptomycin) (PRN (-LRB- -LRB-) (NP (NP (CD 100) (NN µg)) (PP (SYM /) (NP (NN ml)))) (-RRB- -RRB-))))))) (. .)) )
( (HEADING (NP (NNS RESULTS))) )
( (HEADING (NP (NP (NN Identification)) (PP (IN of) (NP (JJ human) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN isoform))))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (SBAR (IN if) (S (NP-SBJ (NP (NNS isoforms)) (PP (IN of) (NP (NN ZBP) (HYPH -) (CD 89)))) (VP (VBP exist))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD screened) (NP (DT the) (JJ human) (NN ZNF148) (JJ genomic) (NN locus)) (ADVP-MNR (FW in) (FW silico)) (PRN (-LRB- -LRB-) (NP (CD 16) (, ,) (CD 17)) (-RRB- -RRB-))) (. .)) )
( (S (PP-TMP (IN After) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG localizing) (NP (NN candidate) (JJ alternative) (NN exon) (NN 4B)) (PP (IN within) (NP (NP (CD 4) (NN kb)) (ADJP (JJ upstream) (PP (IN of) (NP (NN exon) (CD 5)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1A)) (-RRB- -RRB-))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD used) (NP (NML (NN RT) (HYPH –) (NN PCR)) (NN analysis)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB show) (SBAR (IN that) (S (NP-SBJ-1 (NN exon) (NN 4B)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 1B)) (-RRB- -RRB-)))))))))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Exon) (NN 4B)) (NN mRNA) (PRN (-LRB- -LRB-) (NP (NN ΔN)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN co-expressed) (NP-1 (-NONE- *)) (PP (IN with) (NP (ADJP (NP (NN exon) (NN 4A)) (HYPH -) (VBG containing)) (NN message) (PRN (-LRB- -LRB-) (NP (NN FL)) (-RRB- -RRB-)))) (PP-LOC (PP (IN in) (NP (NN colon) (NN cancer) (NNS cells) (PRN (-LRB- -LRB-) (NP (NP (NN ColoDM2)) (, ,) (NP (NN CaCo2)) (, ,) (NP (NN HCT116))) (-RRB- -RRB-)))) (, ,) (CC and) (PP (IN in) (NP (NP (JJ primary) (NN tissue)) (PP (IN from) (NP (NP (JJ normal) (NN colon)) (CC and) (NP (NN colon) (NN adenocarcinoma))))))))) (. .)) )
( (S (NP-SBJ-1 (DT Both) (NNS forms)) (ADVP (RB also)) (VP (VBD were) (ADVP-MNR (RB abundantly)) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN Jurkat) (NNS cells))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ (NP (QP (RB at) (RBS least) (CD two)) (NNS forms)) (PP (IN of) (NP (NN ZBP) (HYPH -) (CD 89)))) (VP (VBP exist))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (ADVP (RBR better)) (VP (VB understand) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (DT the) (NN isoform))))))) (, ,) (NP-SBJ-1 (ADJP (NP (NN exon) (NN 4B)) (HYPH -) (VBG containing)) (NN cDNA)) (VP (VBD was) (VP (VBN sequenced) (NP-1 (-NONE- *)))) (. .)) )
( (S (PP (IN In) (NP (NP (NN addition)) (PP (IN to) (NP (NN exon) (NN 4B))))) (, ,) (NP-SBJ (DT the) (JJ variant) (NN mRNA)) (VP (VBD included) (NP (NP (NNS exons) (NML (CD 5) (CC and) (CD 6)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NNS exons) (NML (NML (CD 7)) (PP (SYM –) (NP (CD 9)))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (-NONE- *PRO*)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-1 (NP (NN RT) (HYPH –) (NN PCR)) (PP (IN with) (NP (JJ forward) (NNS primers))) (PP (IN from) (NP (NNS exons) (NML (NML (CD 1)) (PP (SYM -) (NP (NN 4A))))))) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB generate) (NP (NP (NNS products)) (PP (IN with) (NP (NML (NN exon) (NN 4B)) (NN antisense) (NNS primers)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (DT an) (JJ independent) (NN promoter)) (VP (VBZ regulates) (NP (NML (NN exon) (NN 4B)) (NN expression))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This)) (VP (VBD was) (VP (VBN confirmed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NML (CD 5) (SYM ′)) (HYPH -) (NML (NML (NML (JJ rapid) (NN amplification)) (PP (IN of) (NP (NN cDNA) (NNS ends)))) (-LRB- -LRB-) (NML (NN RACE))) (-RRB- -RRB-)) (, ,) (SBAR (WHNP-3 (WDT which)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-2 (NN transcription)) (VP (VBD was) (VP (VBN initiated) (NP-2 (-NONE- *)) (ADVP-LOC (RB immediately) (RB upstream) (PP (IN of) (NP (NN exon) (NN 4B))))))))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN cDNA) (NN sequence)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-1 (NN exon) (NN 4B)) (VP (VBD was) (VP (VBN spliced) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN exon) (CD 5))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT an) (JJ alternative) (NN reading) (NN frame)) (ADJP (JJ relative) (PP (IN to) (NP (NP (DT the) (NN cDNA)) (VP (VBN encoded) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN exon) (NN 4A))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ (NN Exon) (NN 4B)) (VP (VBD was) (UCP-PRD (NP (NP (CD 329) (NN nt)) (PP (IN in) (NP (NN length)))) (CC and) (VP (VBN composed) (NP (-NONE- *)) (PP (IN of) (NP (JJ untranslated) (NNS sequences))))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN fused) (NP-1 (-NONE- *)) (ADVP-TMP-2 (-NONE- *T*)) (PP (IN to) (NP (NN exon) (CD 5))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBD predicted) (SBAR (IN that) (S (NP-SBJ (NP (JJ alternative) (NN promoter) (NN usage)) (ADVP (RB upstream) (PP (IN of) (NP (NN exon) (NN 4B))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (DT an) (ADJP (ADVP (NN amino) (HYPH -) (RB terminally)) (VBN truncated)) (NML (NN ZBP) (HYPH -) (CD 89)) (NN isoform)) (, ,) (NP (NN ZBP) (HYPH -) (NN 89ΔN)))))) (, ,) (PP-MNR (IN with) (S-NOM (NP-SBJ (DT an) (JJ alternative) (NN initiation) (NN codon)) (VP (VBG corresponding) (PP (IN to) (NP (NP (NN M128)) (PP (IN of) (NP (NML (JJ full) (HYPH -) (NN length)) (NN mRNA)))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2B)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (DT This) (NN isoform)) (VP (VBZ lacks) (NP (NP (DT the) (NML (NML (JJ acidic) (NN domain)) (CC and) (NML (NN p300) (HYPH -) (NN interaction))) (NN region) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-))) (VP (VBN found) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NML (JJ full) (HYPH -) (NN length) (PRN (-LRB- -LRB-) (NP (NN ZBP) (HYPH -) (NN 89FL)) (-RRB- -RRB-))) (NN protein))) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ-1 (JJ Identical) (NNS results)) (VP (VBD were) (VP (VBN obtained) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NN cDNA)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NML (NML (NN esophagus)) (, ,) (NML (NN stomach)) (, ,) (NML (NN colon)) (CC and) (NML (NN Jurkat) (NN T))) (HYPH -) (NNS cells)))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (DT the) (NML (NN exon) (NN 4B)) (JJ alternative) (NN promoter) (NN mechanism)) (VP (VBZ is) (ADJP-PRD (JJ common))))))))) (. .)) )
( (HEADING (NP (NP (NN Detection)) (PP (IN of) (NP (JJ human) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN protein))))) )
( (S (NP-SBJ (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ electrophoretic) (NN mobility)) (PP (IN of) (NP (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN protein))) (, ,) (PP (IN despite) (NP (PRP$ its) (JJR shorter) (NN length)))) (, ,) (VP (VBN overlapped) (PP (IN with) (NP (NP (DT the) (NN mobility)) (PP (IN of) (NP (PRP$ its) (NML (NN ZBP) (HYPH -) (NN 89FL)) (NN cognate))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2C)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (NP (DT Both) (NNS forms)) (, ,) (VP (VBN isolated) (NP (-NONE- *)) (PP (IN from) (NP (NN Jurkat) (NNS cells))))) (, ,) (VP (VBD migrated) (PP (IN at) (NP (CD 100) (NN kDa))) (PP-LOC (IN on) (NP (DT a) (NML (QP (CD 4) (SYM –) (CD 20)) (NN %)) (NN gradient) (NN gel)))) (. .)) )
( (S (NP-SBJ-1 (JJ Similar) (NML (NN SDS) (HYPH –) (NN PAGE)) (NNS anomalies)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (JJ other) (NN proteins)) (, ,) (PP (VBG including) (NP (NP (NN CTCF) (PRN (-LRB- -LRB-) (NP (CD 23)) (-RRB- -RRB-))) (CC and) (NP (NN XPA) (PRN (-LRB- -LRB-) (NP (CD 24)) (-RRB- -RRB-)))))))))) (. .)) )
( (S (NP-SBJ-1 (DT An) (JJ alternative) (NN approach) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB separate) (NP (DT the) (NN protein) (NNS isoforms)))))) (VP (VBD was) (VP (VBN suggested) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG comparing) (NP (PRP$ their) (ADJP (VBN predicted) (PRN (-LRB- -LRB-) (NP (CD 25)) (-RRB- -RRB-))) (JJ isoelectric) (NNS points) (PRN (-LRB- -LRB-) (NP (NN pI)) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ (NP (NN Loss)) (PP (IN of) (NP (DT the) (JJ acidic) (NN domain))) (PP-LOC (IN in) (NP (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN protein)))) (VP (VBD predicted) (NP (NP (DT a) (NN pI)) (PP (IN of) (NP (CD 7.8)))) (, ,) (PP (VBN compared) (PP (IN to) (NP (NP (CD 6.0)) (PP (IN for) (NP (NN ZBP) (HYPH -) (NN 89FL))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN difference)) (VP (MD could) (VP (VB be) (VP (VBN revealed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (ADJP (CD two) (HYPH -) (JJ dimensional) (PRN (-LRB- -LRB-) (NP (JJ 2D)) (-RRB- -RRB-))) (NN gel) (NN electrophoresis)) (, ,) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NML (NNP western) (NN blot)) (NN analysis)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2C)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (NML (NN ZBP) (HYPH -) (CD 89)) (NN antiserum)) (VP (VBD detected) (NP (NP (CD two) (NN protein) (NNS species)) (, ,) (PP (PP (IN with) (NP (NP (JJ apparent) (JJ electrophoretic) (NNS mobilities)) (PP (IN of) (NP (CD 100) (NN kDa))))) (, ,) (CC but) (PP (IN with) (NP (NP (DT a) (NN pI) (NN difference)) (PP (IN of) (NP (QP (SYM ∼) (CD 1.5)))))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG confirming) (SBAR (IN that) (S (NP-SBJ (DT the) (ADJP (RBR more) (JJ basic)) (NN form)) (VP (VBZ is) (NP-PRD (NN ZBP) (HYPH -) (NN 89ΔN)))))))) (. .)) )
( (HEADING (S (NP-SBJ-1 (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (JJ alternative) (NN promoter) (NN mechanism)) (VP (VBZ is) (VP (VBN restricted) (NP-1 (-NONE- *)) (PP (IN to) (NP (NNS hominids))))))) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ (DT the) (UCP (ADJP (JJ human) (PRN (-LRB- -LRB-) (NP (NN ZNF148)) (-RRB- -RRB-))) (CC and) (NML (NN mouse) (PRN (-LRB- -LRB-) (NP (NN Zfp148)) (-RRB- -RRB-)))) (NML (NN ZBP) (HYPH -) (CD 89)) (NNS loci)) (VP (VBP share) (NP (NP (JJ many) (NNS features)) (PP (IN of) (NP (JJ genomic) (NN organization)))) (PRN (-LRB- -LRB-) (NP (CD 11)) (-RRB- -RRB-))))) (, ,) (NP-SBJ (NN exon) (NN 4B)) (VP (VBZ is) (ADJP-PRD (JJ absent)) (PP-LOC (IN in) (NP (NP (NNS mice)) (CC and) (NP (RBS most) (JJ other) (NNS mammals)))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (PRP we)) (VP (VBD identified) (NP (NP (DT a) (NML (CD 133) (NN bp)) (NN segment)) (PP (IN of) (NP (NP (NN chimpanzee) (PRN (-LRB- -LRB-) (NP (NN P.troglodytes)) (-RRB- -RRB-)) (NML (NN chromosome) (CD 3)) (NN sequence)) (PP (IN with) (NP (NP (JJ striking) (NML (NN DNA) (NN sequence)) (NN homology)) (PP (IN to) (NP (JJ human) (NN exon) (NN 4B)))))))))) (, ,) (CC but) (S (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (DT a) (NN gap)) (PP (IN in) (NP (DT the) (VBG existing) (JJ online) (JJ genomic) (NN sequence)))))) (. .)) )
( (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG Sequencing) (PP (IN across) (NP (DT the) (NN gap))) (PP-TMP (IN after) (NP (NML (JJ genomic) (NN DNA)) (NN amplification))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (DT the) (NN chimp)) (VP (VBZ shares) (NP (NP (NML (CD 99) (NN %)) (NN DNA) (NN sequence) (NN identity)) (PP (IN to) (NP (DT the) (NML (CD 329) (NN bp)) (JJ human) (NN exon) (NN 4B)))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ-1 (DT the) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (JJ alternative) (NN promoter) (NN mechanism)) (VP (VBZ is) (VP (VBN restricted) (NP-1 (-NONE- *)) (PP (IN to) (NP (NNS hominids)))))))) (. .)) )
( (HEADING (S (NP-SBJ (-NONE- *PRO*)) (VP (VBG Generating) (NP (NP (DT a) (NN mouse) (NN model)) (PP (IN of) (NP (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN expression))))))) )
( (S (SBAR-PRP (IN Since) (S (NP-SBJ (NNS mice)) (VP (VP (VBP lack) (NP (NN exon) (NN 4B))) (, ,) (CC and) (VP (ADVP (RB therefore)) (VBP do) (RB not) (VP (VB express) (NP (DT a) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN isoform))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD targeted) (NP (DT the) (NN mouse) (NML (NN exon) (CD 4)) (NN domain)) (PP-MNR (IN by) (NP (JJ homologous) (NN recombination))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3A)) (-RRB- -RRB-))) (. .)) )
( (S (S (NP-SBJ (DT The) (JJ left) (NN targeting) (NN arm)) (VP (VBD contained) (NP (NP (NN exon) (CD 3)) (CC and) (NP (NN intron) (CD 3))))) (, ,) (CC and) (S (NP-SBJ (DT the) (JJ right) (NN targeting) (NN arm)) (VP (VBD contained) (NP (NP (CD 1.8) (NN kb)) (PP (IN of) (NP (NP (DT the) (NML (CD 5) (SYM ′)) (NN margin)) (PP (IN of) (NP (NN intron) (CD 4)))))))) (. .)) )
( (S (NP-SBJ (JJ Homologous) (NN recombination)) (VP (VBD occurred) (PP-LOC (IN in) (NP (NP (QP (CD 4) (IN of) (CD 1200)) (NN ES) (NNS clones)) (VP (VBN identified) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN PCR)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3B)) (-RRB- -RRB-))) (. .)) )
( (S (PP-TPC-2 (IN Of) (NP (DT the) (CD four) (JJ homologous) (NNS recombinants))) (, ,) (NP-SBJ-1 (NP (CD three)) (PP-2 (-NONE- *T*))) (VP (VP (VBD demonstrated) (NP (JJ stable) (NNS karyotypes))) (CC and) (VP (VBD were) (ADVP (RB therefore)) (VP (VBN injected) (NP-1 (-NONE- *)) (PP-LOC (IN into) (NP (NNS blastocysts)))))) (. .)) )
( (S (NP-SBJ (NP (NN Germline) (NN transmission)) (PP (IN of) (NP (DT the) (ADJP (NP (NN exon) (CD 4)) (HYPH -) (VBN targeted)) (NN locus)))) (VP (VBD resulted) (PP-LOC (IN in) (NP (NP (CD two) (NN founder) (NNS lines)) (, ,) (NP (NN 4E10) (CC and) (NN 8C6)))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ-1 (NP (DT a) (JJ third) (NN founder)) (, ,) (NP (NN 9C6))) (, ,) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB transmit) (NP (DT the) (JJ recombinant) (NN locus))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Germline) (NN transmission)) (VP (VBD was) (VP (VBN obtained) (NP-1 (-NONE- *)) (ADVP-TMP (RB first)) (PP-LOC (IN in) (NP (DT the) (NN 4E10) (NN lineage))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (RB Near) (HYPH -) (JJ Mendelian)) (NNS ratios)) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN at) (NP (NP (DT the) (NN age)) (PP (IN of) (NP (NN weaning))) (PRN (-LRB- -LRB-) (NP (CD 3) (NNS weeks)) (-RRB- -RRB-)))) (PP-LOC (IN in) (NP (NP (NN offspring)) (PP (IN of) (NP (JJ heterozygous) (NNS intercrosses))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3C)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT The) (NNS data)) (VP (VBD suggested) (SBAR (IN that) (S (S (NP-SBJ (NP (QP (SYM ∼) (CD 20)) (NN %)) (PP (IN of) (NP (ADJP (NN Δexon4) (JJ homozygous)) (NNS embryos)))) (VP (VBP die) (ADVP-MNR (ADVP (FW in) (FW utero)) (CC or) (ADVP (RB perinatally))))) (, ,) (S (ADVP (RB however)) (NP-SBJ (NP (DT the) (NN difference)) (PP (IN between) (NP (ADJP (VBN predicted) (CC and) (VBN observed)) (NML (NN ΔExon4) (HYPH /) (NN ΔExon4)) (NNS yields)))) (VP (VBD was) (RB not) (ADJP-PRD (RB statistically) (JJ significant)) (PRN (-LRB- -LRB-) (NP (NML (NN χ2) (HYPH -) (NN square)) (NN analysis)) (: ;) (S-FRM (NP-SBJ (NN P)) (VP (SYM >) (NP (CD 0.05)))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (DT A) (JJ similar) (NN pattern)) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NN 8C6) (NN lineage))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS results)) (ADVP (RB also)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (DT the) (NN mutant) (NN locus)) (VP (VBD was) (ADJP-PRD (ADVP (ADVP (RB at) (RBS least)) (RB partially)) (JJ functional)) (, ,) (SBAR-PRP (IN since) (S (NP-SBJ-1 (NP (NN heterozygosity)) (PP (IN for) (NP (DT a) (JJ null) (NML (NN ZBP) (HYPH -) (CD 89)) (PRN (-LRB- -LRB-) (NP (NN Zfp148)) (-RRB- -RRB-)) (NN allele)))) (VP (VP (VBZ results) (PP (IN in) (NP (VBN failed) (NML (NN germ) (NN cell)) (NN development)))) (CC and) (VP (ADVP (RB therefore)) (VBZ is) (RB not) (VP (VBN transmitted) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-))))))))))) (. .)) )
( (HEADING (NP (NP (JJ Alternative) (NN splicing)) (PP (IN of) (NP (NP (NN exon) (CD 3)) (PP (IN to) (NP (NN exon) (CD 5))))) (PP-LOC (IN in) (NP (JJ recombinant) (NNS mice))))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (NP (DT the) (NN effect)) (PP (IN of) (NP (NML (NN exon) (CD 4)) (NN deletion))) (PP-LOC (IN on) (NP (NML (NN ZBP) (HYPH -) (CD 89)) (NN expression)))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD analyzed) (NP (NP (NN cDNA)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (ADJP (ADJP (JJ normal)) (, ,) (ADJP (JJ heterozygous)) (CC and) (ADJP (NP (NN exon) (CD 4)) (HYPH -) (VBN targeted))) (NNS animals))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4A)) (-RRB- -RRB-))))) (. .)) )
( (S (SBAR-ADV (IN Whereas) (S (NP-SBJ (NML (NN exon) (CD 4)) (NNS sequences)) (VP (VBD were) (ADJP-PRD (JJ absent) (PP (IN from) (NP (JJ recombinant) (NN mRNA))))))) (, ,) (NP-SBJ-1 (DT both) (ADJP (JJ upstream) (CC and) (JJ downstream)) (NNS exons)) (VP (VBD were) (VP (VBN expressed) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ (NP (NN RT) (HYPH –) (NN PCR)) (PP (IN with) (NP (NP (NNS primers)) (VP (VBG spanning) (NP (NN exon) (CD 4)))))) (VP (VP (VBD generated) (NP=2 (DT a) (NML (CD 690) (NN bp)) (NN cDNA)) (PP=1 (IN from) (NP (JJ wild) (NN type)))) (CC and) (VP (NP=2 (DT a) (NML (CD 339) (NN bp)) (NN cDNA)) (PP=1 (IN from) (NP (NN mutant) (NNS alleles))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN size) (NN difference)) (PP (IN between) (NP (NP (NN WT)) (CC and) (NP (VBN targeted) (NN cDNA))))) (VP (VBD was) (NP-PRD (NP (CD 351) (NN bp)) (, ,) (NP (NP (DT the) (NN size)) (PP (IN of) (NP (NN exon) (CD 4)))))) (. .)) )
( (S (S (NP-SBJ (DT This)) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ-1 (NN exon) (CD 3)) (VP (VBD was) (VP (VBN spliced) (NP-1 (-NONE- *)) (ADVP-MNR (RB directly)) (PP (IN to) (NP (NN exon) (CD 5))) (, ,) (PP (VBG excluding) (NP (DT the) (VBG intervening) (NN Neo) (NN cassette))))))))) (, ,) (CC and) (S (NP-SBJ-2 (DT this)) (VP (VBD was) (VP (VBN confirmed) (NP-2 (-NONE- *)) (PP-MNR (IN by) (NP (NN DNA) (NN sequencing))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4B)) (-RRB- -RRB-))))) (. .)) )
( (S (NP-SBJ (NP (NN Deletion)) (PP (IN of) (NP (NN exon) (CD 4)))) (VP (VP (VBD removed) (NP (NP (DT the) (NN initiation) (NN codon)) (VP (VBN found) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN FL) (NN message)))))) (CC and) (VP (ADVP (RB also)) (VBD resulted) (PP (IN in) (NP (DT an) (JJ alternative) (NN reading) (NN frame))))) (. .)) )
( (S (NP-SBJ (NN Gene) (NN feature) (NN sequence) (NN analysis) (PRN (-LRB- -LRB-) (NP (CD 16) (, ,) (CD 17)) (-RRB- -RRB-))) (VP (VBD predicted) (SBAR (IN that) (S (NP-SBJ (DT the) (JJ alternative) (NN initiation) (NN codon)) (VP (VBD corresponded) (PP (IN to) (NP (NP (NP (NN M128)) (PP (IN of) (NP (DT the) (NN FL) (NN protein) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4B)) (-RRB- -RRB-))))) (, ,) (ADJP (JJ analogous) (PP (IN to) (NP (DT the) (JJ human) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN variant)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2B)) (-RRB- -RRB-)))))) (. .)) )
( (HEADING (NP (NN Mouse) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN protein) (NN expression))) )
( (S (NP-SBJ (JJ 2D) (NML (NNP western) (NN blot)) (NN analysis) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 4C)) (-RRB- -RRB-))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-1 (NML (NML (NN ZBP) (HYPH -) (NN 89FL)) (CC and) (NML (NN ZBP) (HYPH -) (NN 89ΔN))) (NN proteins)) (VP (VBP are) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (DT an) (ADJP (NN allele) (HYPH -) (JJ dependent)) (NN manner)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (CD two) (NNS forms)) (VP (VP (VBP have) (NP (NP (JJ similar) (JJ electrophoretic) (NNS mobilities)) (PP (IN of) (NP (CD 100) (NN kDa))))) (, ,) (CC but) (VP (VBP are) (ADVP (RB readily)) (VP (VBN separated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (PRP$ their) (NN pI) (NNS differences)) (, ,) (ADJP (JJ similar) (PP (IN to) (NP (DT the) (JJ human) (NNS isoforms)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2C)) (-RRB- -RRB-))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN mentioned) (NP-1 (-NONE- *)) (ADVP (RB above))))) (, ,) (NP-SBJ-2 (JJ similar) (JJ electrophoretic) (NNS anomalies)) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (NP-2 (-NONE- *)) (PP-MNR (IN with) (NP (JJ other) (NN protein) (NNS isoforms))) (PRN (-LRB- -LRB-) (NP (CD 23) (, ,) (CD 24)) (-RRB- -RRB-))))) (. .)) )
( (S (S (NP-SBJ (DT The) (NN immunoblot) (NNS data)) (ADVP (RB also)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (DT the) (NN ΔN) (NN protein) (NN isoform)) (VP (MD may) (VP (VB be) (ADJP-PRD (JJ present)) (PP (IN at) (NP (NP (JJR higher) (NNS levels)) (PP (IN than) (NP (DT the) (NN FL) (NN form))))) (PP-LOC (IN in) (NP (NN spleen) (NN tissue))))))))) (, ,) (S (ADVP (RB however)) (NP-SBJ-1 (NN mRNA) (NNS levels)) (VP (VBP appear) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ comparable))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (NP (NP (DT a) (JJ possible) (NN difference)) (PP (IN in) (NP (NN protein) (NN stability)))))))) (. .)) )
( (S (ADVP (RB Collectively)) (, ,) (NP-SBJ (DT the) (NML (NML (NN mRNA)) (CC and) (NML (NN protein) (NN expression))) (NNS data)) (VP (VBD confirmed) (SBAR (IN that) (S (NP-SBJ (PRP we)) (VP (VBD knocked) (NP (DT the) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN variant)) (PP-LOC (IN into) (NP (DT the) (NN mouse) (NN genome))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (DT the) (NN mouse) (NN model)) (VP (VBZ offers) (NP (NP (DT the) (NN advantage)) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG assessing) (NP (NP (DT the) (JJ biological) (NN effect)) (PP (IN of) (NP (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN expression)))) (ADVP (RB exclusively))))))) (. .)) )
( (HEADING (S (NP-SBJ (NML (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN)) (NNS mice)) (VP (VBP experience) (NP (NP (NN growth) (NN delay)) (CC and) (NP (VBN reduced) (NN viability)))))) )
( (S (PP-TMP (IN At) (NP (NN weaning))) (, ,) (PP-TMP (IN by) (NP (NN age) (CD 3) (NNS weeks))) (, ,) (NP-SBJ (JJ male) (NML (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN)) (NNS mice)) (VP (VBD weighed) (NP (NP (NP (DT an) (NN average)) (PP (IN of) (NP (QP (CD 5.9) (SYM ±) (CD 0.5)) (NN g) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5A)) (-RRB- -RRB-))))) (, ,) (ADJP (ADJP (ADJP (NP (CD 34) (NN %)) (JJR smaller)) (PP (IN than) (NP (NN ZBP) (HYPH -) (NN 89FL) (HYPH /) (NN FL) (PRN (-LRB- -LRB-) (NP (QP (CD 12.1) (SYM ±) (CD 0.7)) (NN g)) (-RRB- -RRB-))))) (CC and) (ADJP (ADJP (NP (CD 49) (NN %)) (JJR smaller)) (PP (IN than) (NP (NML (NN ZBP) (HYPH -) (NN 89FL) (HYPH /) (NN ΔN)) (JJ heterozygous) (NNS littermates) (PRN (-LRB- -LRB-) (NP (QP (CD 15.1) (SYM ±) (CD 0.8)) (NN g)) (-RRB- -RRB-)))))))) (. .)) )
( (S (PP (IN From) (NP (NNS ages) (QP (CD 4) (SYM –) (CD 8)) (NNS weeks))) (, ,) (NP-SBJ-1 (NP (DT the) (NN size) (NN differential)) (PP (IN between) (NP (NML (NML (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN)) (CC and) (NML (NN control))) (NNS mice)))) (VP (VBD was) (VP (VBN diminished) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (DT A) (JJ similar) (NN effect)) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN with) (NP (JJ female) (NNS mice))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBN shown) (NP (-NONE- *)) (ADVP (RB above)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3C)) (-RRB- -RRB-))))) (, ,) (NP-SBJ (NML (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN)) (NNS mice)) (VP (VBD experienced) (NP (NML (CD 20) (NN %)) (JJ perinatal) (NN mortality)) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN genotype) (NNS ratios))) (PP-TMP (IN at) (NP (NN weaning))))))) (. .)) )
( (S (NP-SBJ (VBN Reduced) (NN viability)) (VP (VP (VBD persisted)) (CC and) (VP (VBD became) (ADJP-PRD (RB statistically) (JJ significant)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5B)) (-RRB- -RRB-)) (, ,) (PP (IN with) (NP (NP (NP (NML (CD 50) (NN %)) (NN mortality)) (PP-TMP (IN at) (NP (CD 48) (NNS weeks)))) (CC and) (NP (NP (NML (CD 69) (NN %)) (NN mortality)) (PP-TMP (IN by) (NP (CD 104) (NNS weeks)))))))) (. .)) )
( (S (NP-SBJ (DT The) (NML (CD 2) (NN year)) (NN survival) (NNS ratios)) (VP (VBD were) (NP-PRD (NML (NML (NML (CD 20) (SYM :) (CD 20)) (NN ZBP) (HYPH -) (NN 89FL) (HYPH /) (NN FL)) (, ,) (NML (NML (CD 39) (: :) (CD 40)) (NN ZBP) (HYPH -) (NN 89FL) (HYPH /) (NN ΔN)) (CC and) (NML (NML (CD 5) (: :) (CD 16)) (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN))) (NNS mice))) (. .)) )
( (S (NP-SBJ (JJ Histopathological) (NML (NN organ) (CC and) (NN tissue)) (NNS surveys)) (VP (VBD revealed) (NP (NP (DT no) (JJ obvious) (NNS abnormalities)) (PP-LOC (IN in) (NP (NML (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN)) (NNS mice)))) (, ,) (PP (IN with) (NP (NP (DT the) (JJ possible) (NN exception)) (PP (IN of) (NP (NP (DT the) (NN colon)) (, ,) (SBAR (WHADVP-1 (WRB where)) (S (NP-SBJ (PRP we)) (VP (VBD noted) (NP (NP (DT a) (NN trend)) (PP (IN toward) (NP (ADJP (RB slightly) (VBN increased)) (JJ lymphocytic) (NNS infiltrates)))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)) (ADVP-LOC-1 (-NONE- *T*)))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Semi-quantitative) (NML (NN RT) (HYPH –) (NN PCR)) (NN analysis)) (PP (IN of) (NP (NML (NN colon) (NN mRNA)) (NNS levels) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 5C)) (-RRB- -RRB-))))) (, ,) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ-1 (NML (NN FL) (CC and) (NN ΔN)) (NNS forms)) (VP (VBD were) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT an) (ADJP (NN allele) (HYPH -) (JJ dependent)) (NN manner)))))))) (. .)) )
( (S (ADVP (RB Collectively)) (, ,) (NP-SBJ (DT these) (NNS data)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (NP (VBN balanced) (NN expression)) (PP (IN of) (NP (NML (NML (NN ZBP) (HYPH -) (NN 89FL)) (CC and) (NML (NN ZBP) (HYPH -) (NN 89ΔN))) (NNS isoforms)))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (JJ heterozygous) (NNS mice)))))) (, ,) (VP (VBZ supports) (NP (JJ normal) (NML (NN growth) (CC and) (NN viability))))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (JJ exclusive) (NN expression)) (PP (IN of) (NP (DT the) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN isoform))) (PP-LOC (IN in) (NP (JJ transgenic) (NNS mice)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NN growth) (NN delay)) (CC and) (NP (VBN reduced) (NN viability))))) (. .)) )
( (HEADING (S (NP-SBJ (NN ZBP) (HYPH -) (NN 89ΔN)) (VP (VBZ confers) (NP (NN DSS) (NN colitis) (NN susceptibility))))) )
( (S (NP-SBJ (PRP We)) (ADVP-TMP (RB previously)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-1 (NP (DT the) (ADJP (NN amino) (JJ terminal)) (NN region)) (PP (IN of) (NP (NN ZBP) (HYPH -) (CD 89) (PRN (-LRB- -LRB-) (NN amino) (NNS acids) (NML (NML (CD 1)) (PP (SYM –) (NP (CD 111)))) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN required) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB potentiate) (NP (NP (NN butyrate) (NN induction)) (PP (IN of) (NP (NN p21waf1))))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (DT the) (NN amino) (JJ terminal) (NN region)) (VP (VBZ mediates) (NP (NP (DT the) (ADJP (NN butyrate) (HYPH -) (JJ dependent)) (JJ anti-proliferative) (NNS activities)) (PP (IN of) (NP (NN ZBP) (HYPH -) (CD 89)))) (PP-LOC (IN in) (NP (DT the) (JJ mammalian) (JJ gastrointestinal) (NN tract))) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-)))))))))))) (. .)) )
( (S (NP-SBJ (NN Butyrate)) (VP (VBZ suppresses) (NP (JJ colonic) (NN inflammation)) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN induced) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN DSS))) (ADVP-TMP-2 (-NONE- *T*)) (PRN (-LRB- -LRB-) (NP (CD 26)) (-RRB- -RRB-)))))) (. .)) )
( (S (SBAR-PRP (IN Since) (S (NP-SBJ (NN DSS)) (VP (VBZ accentuates) (NP (DT a) (NN tendency) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB develop) (NP (NN colitis))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD challenged) (NP (NML (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN)) (NNS mice)) (ADVP (RB acutely)) (PP (IN with) (NP (NML (CD 4) (NN %)) (NN DSS))) (PP-TMP (IN for) (NP (CD 5) (NNS days))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (-NONE- *PRO*)) (ADVP-TMP (RB previously)) (VP (VBN described) (NP (-NONE- *)) (PRN (-LRB- -LRB-) (NP (CD 20)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ (JJ Histopathogical) (NN analysis) (PRN (-LRB- -LRB-) (NP (ADJP (NP (NN hematoxylin) (CC and) (NN eosin)) (VBN stained)) (NNS sections)) (-RRB- -RRB-))) (VP (VBD demonstrated) (NP (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ severe) (NN colitis)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD correlated) (PP (IN with) (NP (DT a) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN gene) (NN dosage) (NN effect)))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NML (NN 6A)) (PP (SYM –) (NP (NN C))))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NML (NN ZBP) (HYPH -) (NN 89FL) (HYPH /) (NN FL)) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6A)) (-RRB- -RRB-))) (VP (VBD had) (NP (NP (VBN localized) (NNS areas)) (PP (IN of) (NP (NP (JJ lymphocytic) (NN infiltration)) (CC and) (NP (JJ minimal) (JJ submucosal) (NN edema)))))) (. .)) )
( (S (NP-SBJ (NML (NN ZBP) (HYPH -) (NN 89FL) (HYPH /) (NN ΔN)) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6B)) (-RRB- -RRB-))) (VP (VBD exhibited) (NP (ADJP (RBR more) (JJ extensive)) (NN infiltration)) (, ,) (PP (IN with) (NP (NP (VBN displaced) (JJ normal) (NN crypt) (NN architecture)) (PP (IN in) (NP (NP (NN addition)) (PP (IN to) (NP (JJ submucosal) (NN edema)))))))) (. .)) )
( (S (NP-SBJ (NML (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN)) (NNS mice) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6C)) (-RRB- -RRB-))) (VP (VBD had) (NP (NP (NNS areas)) (PP (IN with) (NP (NP (JJ complete) (NN erosion)) (PP (IN of) (NP (NP (NN crypt) (NN architecture)) (, ,) (NP (ADJP (RB grossly) (JJ visible)) (NN hemorrhage)) (CC and) (NP (JJ extensive) (JJ submucosal) (NN edema)))))))) (. .)) )
( (S (NP-SBJ (DT The) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN gene) (NN dosage) (NN effect)) (ADVP (RB also)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (JJ gastrointestinal) (NN bleeding))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6D)) (-RRB- -RRB-))) (. .)) )
( (S (ADVP (RB Moreover)) (, ,) (NP-SBJ (RB only) (NML (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN)) (NNS mice)) (VP (VBD died) (PP-TMP (IN during) (NP (NN DSS) (NN treatment))) (, ,) (PP (IN with) (NP (NML (CD 50) (NN %)) (NN mortality))) (PP-TMP (IN by) (NP (NP (DT the) (NN conclusion)) (PP (IN of) (NP (DT the) (NML (CD 7) (NN day)) (NN regimen))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6E)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (JJ Composite) (NN colitis) (VBG scoring)) (ADVP (RB similarly)) (VP (VBD paralleled) (NP (DT the) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN gene) (NN dosage)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 6F)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-1 (NP (VBN increased) (NN expression)) (PP (IN of) (NP (NN ZBP) (HYPH -) (NN 89ΔN)))) (VP (VBZ is) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (VBN increased) (NN susceptibility)) (PP (IN to) (NP (NN colitis)))))))))) (. .)) )
( (HEADING (NP (NN DISCUSSION))) )
( (S (PP-MNR (IN Through) (NP (ADJP (JJ structural) (CC and) (JJ functional)) (NNS analyses))) (, ,) (NP-SBJ (PRP we)) (VP (VBD identified) (NP (NP (NP (DT a) (ADJP (JJ human) (HYPH -) (JJ specific)) (NML (NN ZBP) (HYPH -) (CD 89)) (NN splice) (NN isoform)) (, ,) (NP (NN ZBP) (HYPH -) (NN 89ΔN))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (VP (VBN generated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (JJ alternative) (NN promoter) (NN usage))) (ADVP-LOC (RB upstream) (PP (IN of) (NP (DT an) (JJ alternative) (NN exon) (NN 4B)))))))))) (. .)) )
( (S (PP (IN As) (NP (DT a) (NN consequence))) (, ,) (NP-SBJ (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN protein)) (VP (VBZ lacks) (NP (NP (DT a) (JJ transcriptional) (NN domain) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-))) (VP (VBN found) (NP (-NONE- *)) (PP-LOC (IN in) (NP (PRP$ its) (NML (JJ full) (HYPH -) (NN length)) (NML (NN ZBP) (HYPH -) (CD 89)) (NN cognate)))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VP (VBZ is) (NP-PRD (NP (DT the) (JJ first) (NN characterization)) (PP (IN of) (NP (DT a) (NML (NN ZBP) (HYPH -) (CD 89)) (NN isoform))))) (CC and) (VP (VBZ is) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (JJ previous) (NNS observations) (SBAR (IN that) (S (NP-SBJ (NN gene) (NN complexity)) (VP (VBZ is) (ADJP-PRD (ADJP (JJR lower)) (PP-1 (-NONE- *ICH*))) (PP-LOC (IN in) (NP (NNS mice))) (PP-1 (IN than) (PP-LOC (IN in) (NP (NNS humans)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (QP (RB As) (JJ many) (IN as) (CD 59)) (NN %)) (PP (IN of) (NP (JJ human) (NNS genes)))) (VP (VBP are) (ADVP-MNR (RB alternatively)) (VP (VBN spliced) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (CD 27)) (-RRB- -RRB-)) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NP (DT the) (JJS highest) (NN estimate)) (PP-TMP (IN to) (NP (NN date))) (PP (IN for) (NP (DT the) (NN mouse)))) (VP (VBZ is) (NP-PRD (CD 33) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 28)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ (JJ Comparative) (JJ genomic) (NN analysis)) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ-1 (DT the) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN splicing) (NN mechanism)) (VP (VBZ has) (VP (VBN been) (VP (VBN conserved) (NP-1 (-NONE- *)) (PP (IN between) (NP (NNS humans) (CC and) (NNS chimps))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ-2 (NP (DT this) (JJ specific) (NN mechanism)) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG regulating) (NP (NML (NN ZBP) (HYPH -) (CD 89)) (NN function)))))) (VP (VBZ is) (VP (VBN restricted) (NP-2 (-NONE- *)) (PP (IN to) (NP (NNS hominids))))))))))))))) (. .)) )
( (S (NP-SBJ (JJ Alternative) (NN mRNA) (NN expression)) (VP (VBZ increases) (NP (JJ genetic) (NN diversity)) (PP-MNR (IN through) (NP (NP (JJ regulatory) (NNS mechanisms)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (ADVP (RB also)) (VP (VBP are) (VP (VBN implicated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NN cancer) (PRN (-LRB- -LRB-) (NP (CD 1)) (, ,) (NP (NP (CD 3)) (PP (SYM –) (NP (CD 5)))) (, ,) (NP (CD 29)) (-RRB- -RRB-))) (CC and) (NP (JJ other) (NN disease) (NNS processes) (PRN (-LRB- -LRB-) (NP (CD 30) (, ,) (CD 31)) (-RRB- -RRB-)))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ human) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN variant)) (VP (VBN described) (NP (-NONE- *)) (ADVP (RB here)))) (VP (VBZ renders) (NP-1 (DT the) (JJ colonic) (NN mucosa)) (S-CLR (NP-SBJ-1 (-NONE- *PRO*)) (ADJP-PRD (RBR more) (JJ susceptible) (PP (IN to) (NP (NN injury)))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (JJ previous) (NNS studies)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-1 (DT the) (ADJP (NN N) (HYPH -) (JJ terminal)) (NN domain)) (VP (VBZ is) (VP (VBN required) (NP-1 (-NONE- *)) (SBAR-PRP (IN for) (S (NP-SBJ (NN ZBP) (HYPH -) (CD 89)) (VP (TO to) (VP (VB mediate) (NP (NP (ADJP (NN butyrate) (HYPH -) (JJ dependent)) (NN activation)) (PP (IN of) (NP (NN p21waf1)))) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG cooperating) (PP (IN with) (NP (NN p300)))))) (PRN (-LRB- -LRB-) (NP (CD 12)) (-RRB- -RRB-))))))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN result)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (DT the) (ADJP (NN N) (JJ terminal)) (NN domain)) (VP (VBZ is) (ADJP-PRD (RB functionally) (JJ important)) (ADVP (FW in) (FW vitro)))))) (. .)) )
( (S (S-NOM-SBJ (NP-SBJ (-NONE- *PRO*)) (VP (VBG Generating) (NP (NP (DT a) (NN mouse) (NN model)) (SBAR (WHPP-1 (IN in) (WHNP (WDT which))) (S (NP-SBJ-2 (RB only) (DT the) (VBN truncated) (NN form)) (VP (VBD was) (VP (VBN expressed) (NP-2 (-NONE- *)) (PP-1 (-NONE- *T*))))))))) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (NP (NN loss)) (PP (IN of) (NP (DT the) (ADJP (NN p300) (HYPH -) (VBG interacting)) (NN domain)))) (VP (VBZ results) (PP (IN in) (NP (NP (VBN delayed) (NN growth)) (CC and) (NP (DT a) (VBN shortened) (NN lifespan)))))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ (NP (DT the) (JJ overall) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN health)) (PP (IN of) (NP (DT the) (NN organism)))))) (VP (VBD was) (ADJP-PRD (JJ impressive))))) (, ,) (NP-SBJ (NP (DT an) (JJ initial) (NN survey)) (PP (IN of) (NP (JJ several) (NNS organs)))) (VP (VBD did) (RB not) (VP (VB reveal) (NP (JJ obvious) (NNS abnormalities)) (, ,) (PP (IN with) (NP (NP (DT the) (NN exception)) (PP (IN of) (NP (NP (DT the) (NN colon)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB exhibit) (NP (NP (ADJP (RB slightly) (JJR more)) (JJ inflammatory) (NNS infiltrates)) (PP (IN than) (NP (DT the) (NML (JJ wild) (NN type)) (NNS mice)))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN propensity) (S-4 (-NONE- *ICH*))) (PP (IN of) (NP (DT the) (ADJP (NP (NN ZBP) (HYPH -) (NN 89ΔN)) (VBG expressing)) (NNS mice))) (S-4 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB develop) (NP (NN colitis)))))) (VP (VBD was) (ADVP-TMP (RB subsequently)) (VP (VBN uncovered) (NP-1 (-NONE- *)) (SBAR (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (DT the) (NNS animals)) (VP (VBD were) (VP (VBN challenged) (NP-2 (-NONE- *)) (PP-MNR (IN with) (NP (NN DSS))) (ADVP-TMP-3 (-NONE- *T*)))))))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (PRP we)) (VP (VBD concluded) (PP (IN from) (NP (DT these) (NNS studies))) (SBAR (IN that) (S (NP-SBJ-1 (NP (NN expression)) (PP (IN of) (NP (NN ZBP) (HYPH -) (NN 89FL)))) (VP (VBZ tends) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB protect) (PP (IN against) (NP (NN colitis)))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NML (NN gene) (NN dosage)) (NN dependence)) (PP (IN of) (NP (NN colitis) (NN susceptibility)))) (ADVP (RB further)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (DT the) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN isoform)) (VP (VBZ functions) (PP (IN as) (NP (NP (DT a) (JJ dominant) (JJ negative) (NN antagonist)) (PP (IN of) (NP (NN ZBP) (HYPH -) (NN 89FL))))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Similar) (JJ antagonistic) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (NP-1 (-NONE- *)) (PP (IN between) (NP (NP (NML (NN FL) (CC and) (NN ΔN)) (NNS isoforms)) (PP (IN within) (NP (DT the) (NN p53) (NN gene) (NN family))))) (, ,) (PP (VBG including) (NP (NP (NN ΔNp63) (PRN (-LRB- -LRB-) (NP (CD 29)) (-RRB- -RRB-))) (CC and) (NP (NN ΔNp73) (PRN (-LRB- -LRB-) (NP (NP (CD 7)) (PP (SYM –) (NP (CD 9)))) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NP (DT The) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (ADJP (VB knock) (HYPH -) (RP in)) (NN model)) (VP (VBN reported) (NP (-NONE- *)) (ADVP (RB here)))) (, ,) (PP (IN along) (PP (IN with) (NP (DT an) (JJR earlier) (NML (NN Zfp148) (SYM +) (HYPH /) (SYM −)) (NN model) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-)))))) (, ,) (VP (VBP help) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB elaborate) (SBAR (WHADVP-2 (WRB how)) (S (NP-SBJ (JJ individual) (NN protein) (NNS domains)) (VP (VBP mediate) (NP (NP (DT the) (ADVP (FW in) (FW vivo)) (NNS functions)) (PP (IN of) (NP (NN ZBP) (HYPH -) (CD 89)))) (ADVP-MNR-2 (-NONE- *T*))))))))) (. .)) )
( (S (NP-SBJ (NP (NNS Mice)) (ADJP (JJ heterozygous) (PP (IN for) (NP (DT a) (JJ null) (NML (NN ZBP) (HYPH -) (CD 89)) (NN allele))))) (VP (VP (VBP demonstrate) (NP (NP (JJ complete) (NN failure)) (PP (IN of) (NP (JJ male) (NML (NN germ) (NN cell)) (NN development))))) (CC and) (VP (VBP are) (ADJP-PRD (JJ defective)) (PP-LOC (IN in) (NP (ADJP (NN p53) (HYPH -) (JJ dependent)) (NN embryogenesis))) (PRN (-LRB- -LRB-) (NP (CD 15)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (DT This) (NN finding)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN ability) (S-1 (-NONE- *ICH*))) (PP (IN of) (NP (NN ZBP) (HYPH -) (CD 89))) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN p53))))))) (VP (VBZ is) (ADJP-PRD (RB exquisitely) (JJ sensitive) (PP (IN to) (NP (NN gene) (NN dosage)))))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (JJ homozygous) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN expression)) (VP (VBZ is) (ADJP-PRD (JJ compatible) (PP (IN with) (NP (ADJP (JJ embryonic) (CC and) (JJ postnatal)) (NN survival)))) (, ,) (NAC (IN albeit) (PP (IN at) (NP (VBN reduced) (NNS levels))))) (. .)) )
( (S (S (NP-SBJ (PRP We)) (ADVP-TMP (RB previously)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (ADJP (NN DNA) (HYPH -) (VBG binding)) (, ,) (NML (NN zinc) (HYPH -) (NN finger)) (NN region)) (PP (IN of) (NP (NN ZBP) (HYPH -) (CD 89)))) (VP (VBZ mediates) (NP (NP (PRP$ its) (NN interaction)) (PP (IN with) (NP (NN p53)))) (PRN (-LRB- -LRB-) (NP (CD 13)) (-RRB- -RRB-))))))) (, ,) (CC and) (S (NP-SBJ-1 (DT this) (NN domain)) (VP (VBZ is) (VP (VBN retained) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT the) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN isoform)))))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (NP (DT the) (NN Nter) (NN domain)) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ includes) (NP (DT the) (NML (NN p300) (NN interaction)) (NN domain)))))) (, ,) (VP (VP (VBZ is) (ADJP-PRD (JJ dispensable) (PP (IN for) (NP (NP (ADJP (NN p53) (HYPH -) (JJ dependent)) (JJ embryonic) (NN development)) (CC and) (NP (JJ postnatal) (NN survival)))))) (, ,) (CC but) (VP (VBZ is) (ADJP-PRD (JJ essential) (PP (IN for) (NP (JJ normal) (JJ gastrointestinal) (NN function)))))) (. .)) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ (DT The) (NNS authors)) (ADVP-MNR (RB gratefully)) (VP (VBP acknowledge) (NP (NP (DT the) (NN expertise)) (PP (IN of) (NP (NP (NML (NML (DT the) (NNP University)) (PP (IN of) (NP (NNP Michigan)))) (NML (NNP Transgenic) (NNP Animal) (NNP Model)) (NNP Core)) (, ,) (NP (ADVP (RB especially)) (NP (NNP Thom) (NNP Saunders)) (, ,) (NP (NNP Linda) (NNP Samuelson)) (CC and) (NP (NNP Elizabeth) (NNP Hughes))))))) (. .)) )
( (S (NP-SBJ (DT The) (NNS authors)) (ADVP (RB also)) (VP (VP (VBP thank) (NP=1 (NP (NNS members)) (PP (IN of) (NP (NP (NP (DT the) (NML (NN DNA) (NN Sequencing)) (NN Core)) (CC and) (NP (NP (DT the) (NNP Unit)) (PP (IN for) (NP (NNP Laboratory) (NNP Animal) (NNP Medicine))))) (PP (IN at) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Michigan))))))))) (, ,) (CC and) (VP (NP=1 (NNP Kathy) (NNP McClinchey)) (PP (IN for) (NP (NP (NN assistance)) (PP (IN with) (NP (NN histology))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Proteomics) (NNS data)) (VP (VBD were) (VP (VBN provided) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NNP Michigan) (NNP Proteome) (NNP Consortium)) (-LRB- -LRB-) (-RRB- -RRB-) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ is) (VP (VBN supported) (NP-2 (-NONE- *)) (PP (IN in) (ADJP (JJ part))) (PP (IN by) (NP-LGS (NP (NNS funds)) (PP (IN from) (NP (DT the) (NML (NNP Michigan) (NNP Life) (NNPS Sciences)) (NNP Corridor))))))))))))) (. .)) )
( (S (ADVP (RB Specifically)) (, ,) (NP-SBJ-1 (NP (JJ valuable) (NN assistance)) (PP (IN with) (NP (NML (JJ 2D) (NN gel)) (NN electrophoresis)))) (VP (VBD was) (VP (VBN provided) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NNP Jennifer) (NNP Callahan))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN research)) (VP (VBZ is) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN in) (ADJP (JJ part))) (PP (IN by) (NP-LGS (NP (DT the) (NNP National) (NNPS Institutes)) (PP (IN of) (NP (NNP Health))))) (PP (IN through) (NP (NP (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Michigan) (POS 's)))) (NML (NNP Cancer) (NNP Center)) (NNP Support) (NNP Grant) (PRN (-LRB- -LRB-) (NP (CD 5) (NN P30) (NN CA46592)) (-RRB- -RRB-))) (CC and) (NP (NML (NML (DT the) (NNP University)) (PP (IN of) (NP (NNP Michigan)))) (NML (NNP Gastrointestinal) (NNP Peptide)) (NNP Research) (NNP Center) (PRN (-LRB- -LRB-) (NP (NN DK) (HYPH -) (CD 34533)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ (NP (NNP Art) (NNP Tessier)) (CC and) (NP (NNP Gail) (NNP Kelsey))) (VP (VBD provided) (NP (JJ administrative) (NN support))) (. .)) )
( (S (NP-SBJ (NNP Stacey) (NNP Ehrenberg)) (VP (VBD provided) (NP (JJ technical) (NN assistance))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN work)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNS grants)) (PP (IN from) (NP (NP (DT the) (NNP National) (NNPS Institutes)) (PP (IN of) (NP (NNP Health))))) (PP (IN to) (NP (NP (NNP D.J.L.) (PRN (-LRB- -LRB-) (NP (NN R21) (NN DK65004) (HYPH -) (CD 01)) (-RRB- -RRB-))) (CC and) (NP (NNP J.L.M.) (PRN (-LRB- -LRB-) (NP (NN RO1) (HYPH -) (NN DK55732)) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Funding)) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB pay) (NP (NP (DT the) (NML (NNP Open) (NNP Access)) (NN publication) (NNS charges)) (PP (IN for) (NP (DT this) (NN article))))))))) (VP (VBD was) (VP (VBN provided) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NML (NNP NIH) (NN grant)) (NN RO1) (HYPH -) (NN DK55732))) (PRN (-LRB- -LRB-) (NP (NNP J.L.M.)) (-RRB- -RRB-)))) (. .)) )
( (HEADING (NP (NP (NN Conflict)) (PP (IN of) (NP (NN interest) (NN statement))) (. .))) )
( (FRAG (NP-SBJ-1 (NN None)) (VP (VBN declared) (NP-1 (-NONE- *))) (. .)) )
( (HEADING (NP (NNS Figures) (CC and) (NNS Tables))) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (CAPTION (NP (NP (NN Identification)) (PP (IN of) (NP (DT a) (JJ novel) (NN exon))) (PP (IN within) (NP (DT the) (JJ human) (NML (NN ZBP) (HYPH -) (CD 89) (PRN (-LRB- -LRB-) (NP (NN ZNF148)) (-RRB- -RRB-))) (NN locus))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ (DT The) (JJ human) (NML (NN ZBP) (HYPH -) (CD 89) (PRN (-LRB- -LRB-) (NP (NN ZNF148)) (-RRB- -RRB-))) (NN locus)) (VP (VP (VBZ spans) (NP (CD 142) (NN kb)) (PRN (-LRB- -LRB-) (NP (JJ upper) (NN panel)) (-RRB- -RRB-))) (CC and) (VP (VBZ encompasses) (NP (NP (CD three) (JJ untranslated) (PRN (-LRB- -LRB-) (NP (NP (CD 1)) (PP (SYM –) (NP (CD 3)))) (-RRB- -RRB-)) (NML-1 (-NONE- *RNR*))) (CC and) (NP (CD six) (NN coding) (PRN (-LRB- -LRB-) (NP (NP (CD 4)) (PP (SYM –) (NP (CD 9)))) (-RRB- -RRB-)) (NML-1 (-NONE- *RNR*))) (NML-1 (NNS exons))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT A) (JJ potential) (JJ alternative) (NN exon) (NN 4B) (PRN (-LRB- -LRB-) (NP (VBN shaded) (NN box)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN identified) (NP-1 (-NONE- *)) (PP-LOC (IN at) (NP (NP (DT a) (NN position)) (ADVP-LOC (NP (CD 4.2) (NN kb)) (RB upstream) (PP (IN of) (NP (NN exon) (CD 5)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NNS Arrows)) (VP (VBP indicate) (NP (NP (NP (DT the) (NNS locations)) (PP (IN of) (NP (ADJP (ADJP (JJ forward) (PRN (-LRB- -LRB-) (NP (NN F)) (-RRB- -RRB-))) (CC and) (ADJP (JJ reverse) (PRN (-LRB- -LRB-) (NP (NN R)) (-RRB- -RRB-)))) (NML (NN RT) (HYPH –) (NN PCR)) (NNS primers)))) (VP (VBN used) (NP (-NONE- *)) (PP (IN for) (NP (NP (NN expression) (NN analysis)) (PP (IN of) (NP (NP (NN FL) (NN ZBP) (HYPH -) (CD 89)) (CC and) (NP (DT the) (NML (NN exon) (NN 4B)) (NN variant))))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (VBN Selected) (NN intron) (NNS sizes) (PRN (-LRB- -LRB-) (NP (NN kb)) (-RRB- -RRB-))) (VP (VBP are) (VP (VBN indicated) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NP (NML (NN RT) (HYPH –) (NN PCR)) (NN analysis)) (PP (IN of) (NP (ADJP (ADJP (JJ full) (HYPH -) (NN length) (PRN (-LRB- -LRB-) (NP (NN FL)) (-RRB- -RRB-))) (CC and) (ADJP (NN variant) (PRN (-LRB- -LRB-) (NP (NN ΔN)) (-RRB- -RRB-)))) (NML (NN ZBP) (HYPH -) (CD 89)) (NN mRNA) (NN expression)))) (, ,) (VP (VBG using) (NP (NN actin) (PRN (-LRB- -LRB-) (NP (NN Ac)) (-RRB- -RRB-))) (PP (IN as) (NP (NN control)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (NNS cDNAs)) (VP (VBD were) (VP (VBN generated) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (VBN cultured) (NN cell) (NNS lines))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NNS primers) (NN 4A) (HYPH -) (NN F) (HYPH /) (CD 5) (HYPH -) (NN R) (PRN (-LRB- -LRB-) (NP (NML (CD 726) (NN bp)) (NN product)) (-RRB- -RRB-))) (: ;) (NP (NNS primers) (NN 4B) (HYPH -) (NN F) (HYPH /) (CD 6) (HYPH -) (NN R) (PRN (-LRB- -LRB-) (NP (NML (CD 432) (NN bp)) (NN product)) (-RRB- -RRB-))) (CC and) (-LRB- -LRB-) (NP (NML (NML (NN Ac)) (-RRB- -RRB-) (, ,) (NML (NN Actin) (NN control))) (NNS primers) (PRN (-LRB- -LRB-) (NP (NML (CD 400) (NN bp)) (NN product)) (-RRB- -RRB-)))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NML (JJ Whole) (NN cell)) (NN RNA)) (VP (VBD was) (VP (VBN isolated) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NML (NML (NN ColoDM2)) (, ,) (NML (NN CaCo) (CD 2)) (, ,) (CC and) (NML (NN HCT116))) (JJ human) (NN colon) (NN cell) (NNS lines)) (CONJP (RB as) (RB well) (IN as)) (NP (NP (VBN paired) (JJ normal) (NN colon)) (CC and) (NP (NN colon) (NN adenocarcinoma) (NN tissue))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (NML (JJ Full) (HYPH -) (NN length)) (NN message)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NN promoter) (CD 1)) (-LRB- -LRB-) (NP (NN Pro) (CD 1)))))) (-RRB- -RRB-)) (CC and) (S (NP-SBJ (JJ variant) (-LRB- -LRB-) (NN ΔN) (-RRB- -RRB-) (NML (NN ZBP) (HYPH -) (CD 89)) (NN mRNA)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP (IN from) (NP (NN promoter) (CD 2) (PRN (-LRB- -LRB-) (NP (NN Pro) (CD 2)) (-RRB- -RRB-)))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBN described) (NP (-NONE- *)) (PP (IN in) (NP (NN Figure) (CD 2))))))))) (. .))) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (CAPTION (S (NP-SBJ (JJ Variant) (NML (NN ZBP) (HYPH -) (CD 89)) (NN transcript)) (VP (VBZ encodes) (NP (NP (DT a) (VBN truncated) (NN protein)) (, ,) (NP (NN ZBP) (HYPH -) (NN 89ΔN)))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ-1 (NP (NP (DT The) (NML (CD 5) (SYM ′)) (NN end)) (PP (IN of) (NP (ADJP (NP (NN exon) (NN 4B)) (HYPH -) (JJ variant)) (NN cDNA)))) (, ,) (VP (VBN determined) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NML (CD 5) (SYM ′)) (HYPH -) (NN RACE))))) (, ,) (VP (VBZ is) (VP (VBN shown) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (FRAG (FRAG (NP (JJ Underlined) (NNS italics)) (, ,) (ADJP (NP (NN exon) (NN 4B)) (HYPH -) (VBN encoded))) (: ;) (FRAG (NP (JJ lower) (NN case) (NNS italics)) (, ,) (NP (NML (NN exon) (CD 5)) (JJ untranslated) (PRN (-LRB- -LRB-) (NP (NP (NN frameshift)) (ADJP (JJ relative) (PP (IN to) (NP (NML (NN ZBP) (HYPH -) (NN 89FL)) (NN cDNA))))) (-RRB- -RRB-)))) (: ;) (FRAG (NP (JJ upper) (NN case) (NNS italics)) (, ,) (NP (NP (NP (NML (NN exon) (CD 5)) (NN coding) (NN sequence)) (VP (VBG commencing) (PP (IN at) (NP (NN M128))))) (ADJP (JJ relative) (PP (IN to) (NP (NN FL) (NN protein)))))) (: ;) (FRAG (NP (JJ upper) (NN case) (VBN underlined)) (, ,) (NP (NP (NN beginning)) (PP (IN of) (ADJP (NP (NN exon) (CD 6)) (HYPH -) (VBN encoded))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NN remainder)) (PP (IN of) (NP (DT the) (NML (NML (NN cDNA)) (CC and) (NML (NN amino) (NN acid))) (NNS sequences)))) (VP (VBP are) (ADJP-PRD (JJ identical) (PP (IN to) (NP (NP (DT the) (VBG corresponding) (NNS segments)) (PP (IN of) (NP (NP (NN FL) (NN cDNA)) (CC and) (NP (NN protein)))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN Comparison)) (PP (IN of) (NP (NML (NML (NN FL) (PRN (-LRB- -LRB-) (ADJP (JJ upper)) (-RRB- -RRB-))) (CC and) (NML (NN ΔN) (PRN (-LRB- -LRB-) (ADJP (JJ lower)) (-RRB- -RRB-)))) (NN protein) (NNS isoforms))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NN amino) (NN terminus)) (PP (IN of) (NP (NN ZBP) (HYPH -) (NN 89FL)))) (VP (VBZ includes) (NP (NP (DT an) (UCP (ADJP (JJ acidic)) (CC and) (NML (NN p300) (HYPH -) (NN interaction))) (NN domain) (PRN (-LRB- -LRB-) (NP (NN PID)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (ADJP-PRD (JJ absent)) (PP-LOC (IN in) (NP (NN ZBP) (HYPH -) (NN 89ΔN)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN isoform)) (VP (VBZ retains) (NP (DT the) (UCP (NML (NN DNA) (NN binding)) (CC and) (ADJP (NN C) (HYPH -) (JJ terminal))) (NNS domains))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (JJ 2D) (NML (NNP western) (NN blot)) (NN analysis)) (PP (IN of) (NP (NN Jurkat) (NML (JJ whole) (NN cell)) (NN protein) (NN extract))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NML (NML (NN ZBP) (HYPH -) (NN 89FL) (PRN (-LRB- -LRB-) (NP (JJ solid) (NN triangle)) (-RRB- -RRB-))) (CC and) (NML (NN ZBP) (HYPH -) (NN 89ΔN) (PRN (-LRB- -LRB-) (NP (JJ open) (NN triangle)) (-RRB- -RRB-)))) (NNS peptides)) (VP (VP (VBP share) (NP (NP (DT an) (JJ electrohoretic) (NN mobility)) (PP (IN of) (NP (QP (SYM ∼) (CD 100)) (NN kDa))))) (CC and) (VP (VBP are) (VP (VBN separated) (NP-1 (-NONE- *)) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (PRP$ their) (JJ distinct) (JJ isoelectric) (NNS points) (PRN (-LRB- -LRB-) (NP (NN pI)) (-RRB- -RRB-))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (JJ acidic) (NN end)) (PP (IN of) (NP (DT the) (NN focusing) (NN gel)))) (VP (VBZ is) (PP-PRD (IN at) (NP (DT the) (NN left)))) (. .))) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (CAPTION (NP (NP (VBG Targeting) (NML (NN ZBP) (HYPH -) (CD 89)) (NN exon) (CD 4)) (PP-LOC (IN in) (NP (NNS mice))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NN Replacement)) (PP (IN of) (NP (NN exon) (CD 4))) (PP (IN with) (NP (DT a) (NN Neomycin) (NN resistance) (NN cassette) (PRN (-LRB- -LRB-) (NP (NN NEO)) (-RRB- -RRB-)))) (PP (IN by) (NP (NP (JJ homologous) (NN recombination)) (PP-LOC (IN in) (NP (NN ES) (NNS cells))))) (. .))) )
( (CAPTION (FRAG (NP (JJ Top) (NN panel)) (: :) (S (NP-SBJ (NN bracket)) (VP (VBZ shows) (NP (NP (NN location)) (PP (IN of) (NP (NP (NP (NNS features)) (VP (VBN encoded) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN exon) (CD 4))))) (, ,) (PP (VBG including) (NP (NP (NN initiation) (NN codon)) (, ,) (NP (JJ acidic) (NN domain) (PRN (-LRB- -LRB-) (NP (JJ black) (NN rectangle)) (-RRB- -RRB-))) (CC and) (NP (NN p300) (NN interaction) (NN domain))))))))) (. .))) )
( (CAPTION (FRAG (FRAG (NP (JJ Open) (NNS boxes)) (, ,) (NP (JJ basic) (NNS domains))) (: ;) (FRAG (NP (VBN hatched) (NNS boxes)) (, ,) (NP (NN zinc) (HYPH -) (NNS fingers))) (: ;) (FRAG (NP (VBN stippled) (NN region)) (, ,) (ADJP (JJ untranslated))) (. .))) )
( (CAPTION (FRAG (NP (JJ Middle) (NN panel)) (: ;) (NP (NN Zfp148) (JJ genomic) (NN locus)) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Intron) (NNS sizes) (PRN (-LRB- -LRB-) (NP (NN kb)) (-RRB- -RRB-))) (VP (VBP are) (VP (VBN shown) (NP-1 (-NONE- *)))) (. .))) )
( (CAPTION (FRAG (NP (JJ Lower) (NN panel)) (: ;) (NP (NN targeting) (NN strategy)) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NML (NN Tail) (NN biopsy)) (NN DNA) (NN genotyping) (. .))) )
( (CAPTION (NP (NML (NML (NN WT) (PRN (-LRB- -LRB-) (NP (NN Int) (CD 3) (NN F) (HYPH /) (NN Int) (CD 4) (NN R)) (-RRB- -RRB-))) (CC and) (NML (NN Δexon4) (PRN (-LRB- -LRB-) (NP (NNP Int) (CD 3) (NN F) (HYPH /) (NN Neo) (NN R)) (-RRB- -RRB-)))) (NNS amplimers) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (ADJP (RB Near) (HYPH -) (JJ Mendelian)) (NN inheritance)) (PP (IN of) (NP (NML (NN ΔExon) (HYPH -) (CD 4)) (NNS alleles))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NNS differences)) (PP (IN between) (NP (ADJP (VBN predicted) (CC and) (VBN observed)) (NNS values)))) (VP (VBD were) (RB not) (ADJP-PRD (JJ significant))) (. .))) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (CAPTION (S (NP-SBJ (NN ΔExon4) (NN locus)) (VP (VBZ encodes) (NP (NN mouse) (NN ZBP) (HYPH -) (NN 89ΔN))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP-SBJ-1 (NML (NN RT) (HYPH –) (NN PCR)) (NN analysis)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (DT the) (JJ variant) (NN mRNA) (NN structure)) (PP-LOC (IN in) (NP (JJ recombinant) (NNS mice)))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NN Spleen) (NML (JJ whole) (HYPH -) (NN cell)) (NN RNA)) (VP (VBD was) (VP (VP (RB reverse) (HYPH -) (VBN transcribed) (NP-1 (-NONE- *))) (CC and) (VP (VBN amplified) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NNS primers))) (PP-LOC (IN within) (NP (DT the) (JJ indicated) (NNS exons)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NN RT) (HYPH –) (NN PCR)) (PP (IN of) (NP (NP (DT another) (ADJP (RB ubiquitously) (VBN expressed)) (NML (NN zinc) (HYPH -) (NN finger)) (NN transcription) (NN factor)) (, ,) (NP (NN Sp1))))) (, ,) (VP (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN for) (NP (NN comparison))))) (CC and) (VP (VBD showed) (NP-1 (-NONE- *)) (SBAR (IN that) (S (NP-SBJ (DT the) (NN RNA) (NNS samples)) (VP (VBD were) (PP-PRD (IN of) (NP (JJ uniform) (NN quality)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Control) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NN PCR) (NNS products)) (VP (VBD were) (ADJP-PRD (NN RT) (HYPH -) (JJ dependent)) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ-1 (PRP they)) (VP (VBD were) (ADVP (RB indeed)) (VP (VP (VBN derived) (NP-1 (-NONE- *)) (PP (IN from) (NP (NN mRNA)))) (CONJP (RB rather) (IN than)) (VP (ADVP (RB possibly)) (VBG resulting) (PP (IN from) (NP (NP (NN amplification)) (PP (IN of) (NP (NP (ADJP (NP (NN ZBP) (HYPH -) (CD 89)) (VBN related)) (VBN processed) (NN pseudogene) (NNS sequences)) (, ,) (PP (JJ such) (IN as) (NP (NN ΨBERF1))))))) (PRN (-LRB- -LRB-) (NP (CD 32)) (-RRB- -RRB-))))))))))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP-SBJ (NP (NN DNA) (NN sequencing)) (PP (IN of) (NP (JJ recombinant) (NN cDNA)))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NP (NN deletion)) (PP (IN of) (NP (NN exon) (CD 4)))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ direct) (NN splicing)) (PP (IN of) (NP (NN exon) (CD 3))) (PP (IN to) (NP (NN exon) (CD 5))))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG excluding) (NP (DT the) (NN Neo) (NN cassette)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (VBG resulting) (NN reading) (NN frameshift)) (VP (VBZ predicts) (NP (NP (NP (DT an) (JJ alternative) (NN initiation) (NN codon)) (VP (VBG corresponding) (PP (IN to) (NP (NP (NN M128)) (PP (IN of) (NP (NN FL) (NN protein))))))) (, ,) (ADJP (JJ similar) (PP (IN to) (NP (DT the) (ADJP (RB naturally) (VBG occurring)) (JJ human) (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NN variant)))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (NP (JJ 2D) (NN immunoblot) (NN analysis)) (PP (IN of) (NP (NP (NML (JJ whole) (HYPH -) (NN cell)) (NN spleen) (NN protein) (NNS extracts)) (PP (IN from) (NP (NML (NML (NN FL) (HYPH /) (NN FL)) (, ,) (NML (NN FL) (HYPH /) (NN ΔN)) (CC and) (NML (NN ΔN) (HYPH /) (NN ΔN))) (NNS mice)))))) (, ,) (VP (VBG using) (NP (NP (NNS conditions)) (ADJP (JJ identical) (PP (IN to) (NP (NP (DT those)) (VP (VBN used) (NP (-NONE- *)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (JJ human) (NNS samples)))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2C)) (-RRB- -RRB-))) (. .))) )
( (HEADING (NP (NN Figure) (CD 5))) )
( (CAPTION (NP (NP (NP (NN Growth) (NN delay)) (CC and) (NP (VBN decreased) (NN survival))) (PP-LOC (IN in) (NP (NN ΔNter) (NNS mice))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NN Growth) (NN curve)) (PP (IN for) (NP (JJ male) (NML (NML (NN ZBP) (HYPH -) (NN 89FL) (HYPH /) (NN FL) (PRN (-LRB- -LRB-) (NP (JJ gray) (VBN dashed) (NN line)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 20)))) (-RRB- -RRB-))) (, ,) (NML (NN ZBP) (HYPH -) (NN 89FL) (HYPH /) (NN ΔN) (PRN (-LRB- -LRB-) (NP (JJ black) (VBN dotted) (NN line)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 36)))) (-RRB- -RRB-))) (, ,) (CC and) (NML (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN) (PRN (-LRB- -LRB-) (NP (JJ black) (JJ solid) (NN line)) (, ,) (S-FRM (NP-SBJ (NN n)) (VP (SYM =) (NP (CD 16)))) (-RRB- -RRB-)))) (NN offspring))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT A) (JJ similar) (NN pattern)) (VP (VBD was) (VP (VBN seen) (NP-1 (-NONE- *)) (PP (IN with) (NP (JJ female) (NNS mice))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (-NONE- *PRO*)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (S-FRM (LST (LS **)) (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.01)))) (: ;) (S-FRM (LST (LS *)) (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.05)))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT A) (NN trend)) (PP (IN toward) (NP (JJR lower) (NN body) (NNS weights))) (PP-LOC (IN in) (NP (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN)))) (VP (VP (VBD persisted) (PP-TMP (IN after) (NP (CD 12) (NNS weeks)))) (, ,) (CC but) (VP (VBD was) (ADVP-TMP (RB no) (RBR longer)) (ADJP-PRD (RB statistically) (JJ significant)) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NML (NNP Kaplan) (HYPH –) (NNP Meier)) (NN analysis)) (PP (IN of) (NP (NP (NN survival) (NN interval)) (PP (IN to) (NP (NP (DT the) (NN onset)) (PP (IN of) (NP (NN morbidity) (CC or) (NN death))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (JJ Semi-quantitative) (NML (NN RT) (HYPH –) (NN PCR)) (NN analysis)) (PP (IN of) (NP (NML (NML (NN ZBP) (HYPH -) (NN 89FL)) (CC and) (NML (NN ZBP) (HYPH -) (NN 89ΔN))) (NN mRNA) (NNS levels))) (PP-LOC (IN in) (NP (DT the) (NN colon))) (. .))) )
( (HEADING (NP (NN Figure) (CD 6))) )
( (CAPTION (NP (NP (VBN Increased) (NN susceptibility)) (PP (IN to) (NP (NN DSS) (NN colitis))) (PP-LOC (IN in) (NP (NML (NN ZBP) (HYPH -) (NN 89ΔN)) (NNS mice))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS A) (SYM –) (LS C) (-RRB- -RRB-)) (NP (JJ Representative) (NML (NN H) (CC &) (NN E)) (NNS stains)) (PP (IN of) (NP (UCP (ADJP (JJ normal) (PRN (-LRB- -LRB-) (NP (NN A)) (-RRB- -RRB-))) (, ,) (ADJP (JJ heterozygous) (PRN (-LRB- -LRB-) (NP (NN B)) (-RRB- -RRB-))) (CC and) (NML (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ΔN) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-)))) (NNS mice))) (. .))) )
( (CAPTION (S (S-FRM (NP-SBJ (NN Inf)) (VP (SYM =) (NP (VBG infiltrating) (NNS lymphocytes)))) (: ;) (S-FRM (NP-SBJ (NN SE)) (VP (SYM =) (NP (JJ submucosal) (NN edema)))) (: ;) (S-FRM (NP-SBJ (NN TM)) (VP (SYM =) (NP (JJ transmural) (NN inflammation)))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-)) (NP-SBJ (NN ΔNter) (NN expression)) (VP (VBZ accelerates) (NP (NP (NP (NN onset)) (PP (IN of) (NP (JJ gastrointestinal) (NN bleeding)))) (, ,) (VP (VBN measured) (NP (-NONE- *)) (PP (IN by) (NP-LGS (JJ fecal) (JJ occult) (NN blood) (NN screening)))))) (. .))) )
( (CAPTION (FRAG (LST (-LRB- -LRB-) (LS E) (-RRB- -RRB-)) (NP (NP (NN Mortality)) (PP-TMP (IN during) (NP (NN DSS) (NN treatment)))) (: :) (S (NP-SBJ (NP (CD 50) (NN %)) (PP (IN of) (NP (NML (NN ZBP) (HYPH -) (NN 89ΔN) (HYPH /) (NN ZBP) (HYPH -) (NN 89ΔN)) (NNS mice)))) (VP (VBP die) (PP-TMP (IN during) (NP (NML (CD 4) (NN %)) (NN DSS) (NN treatment))))) (: ;) (S (NP-SBJ (DT all) (NML (NML (NN ZBP) (HYPH -) (NN 89FL) (HYPH /) (NN ZBP) (HYPH -) (NN 89FL)) (CC and) (NML (NN ZBP) (HYPH -) (NN 89FL) (HYPH /) (NN ZBP) (HYPH -) (NN 89ΔN))) (NNS mice)) (VP (VBD survived) (PRN (-LRB- -LRB-) (NP (NP (CD six)) (PP (IN in) (NP (DT each) (NN group)))) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS F) (-RRB- -RRB-)) (NP (NP (NML (NN Colitis) (NN index)) (NN scoring)) (PP (IN of) (NP (ADJP (NN DSS) (HYPH -) (VBN treated)) (NNS mice))) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBN described) (NP (-NONE- *)) (PP (IN in) (NP (NNS Materials) (CC and) (NNS Methods))))))) (: ;) (NP (NP (CD six) (NNS mice)) (PP-LOC (IN in) (NP (DT each) (NN genotype) (NN cohort)))) (. .))) )
